
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE53336D8AF27BF305336D000441C5A0.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="rscsd">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nanoscale Horizons">
<meta name="citation_title" content="Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors">
<meta name="citation_author" content="Stephanie R Zelenetz">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author" content="Haeik Park">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author" content="Wenan Qiang">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA">
<meta name="citation_author_institution" content="Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago 60611, Illinois, USA">
<meta name="citation_author" content="Gan Lin">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA">
<meta name="citation_author" content="Sultan Almunif">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Bioengineering Institute, King Abdulaziz City for Science and Technology, Riydah 12354, Saudi Arabia">
<meta name="citation_author" content="Swagat H Sharma">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author" content="Debora B Scariot">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA">
<meta name="citation_author" content="Junlin Lu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Department of Chemical and Biological Engineering, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author" content="Robert W Reichert">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author" content="Bin Zhang">
<meta name="citation_author_institution" content="Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago 60611, Illinois, USA">
<meta name="citation_author_institution" content="Department of Medicine, Hematology/Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA">
<meta name="citation_author" content="Evan A Scott">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu">
<meta name="citation_author_institution" content="Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA">
<meta name="citation_publication_date" content="2025 Jun 24">
<meta name="citation_volume" content="10">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="2003">
<meta name="citation_doi" content="10.1039/d5nh00206k">
<meta name="citation_pmid" content="40552380">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/">
<meta name="description" content="While monoclonal antibodies have significantly improved cancer treatment, their accumulation in off-target tissues not only limits efficacy, but also induces toxicity. A major contributor to this problem is the mononuclear phagocyte system (MPS). ...">
<meta name="og:title" content="Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="While monoclonal antibodies have significantly improved cancer treatment, their accumulation in off-target tissues not only limits efficacy, but also induces toxicity. A major contributor to this problem is the mononuclear phagocyte system (MPS). ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12186146">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1039/d5nh00206k"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12186146%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12186146/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12186146/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-rscsd.png" alt="Royal Society of Chemistry logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Royal Society of Chemistry" title="Link to Royal Society of Chemistry" shape="default" href="https://doi.org/10.1039/d5nh00206k" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nanoscale Horiz</button></div>. 2025 Jun 24;10(9):2003–2016. doi: <a href="https://doi.org/10.1039/d5nh00206k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1039/d5nh00206k</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Nanoscale%20Horiz%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nanoscale%20Horiz%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nanoscale%20Horiz%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nanoscale%20Horiz%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors<sup><a href="#fn1" class="usa-link">†</a></sup>
</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zelenetz%20SR%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Stephanie R Zelenetz</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Stephanie R Zelenetz</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zelenetz%20SR%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephanie R Zelenetz</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Haeik Park</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Haeik Park</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haeik Park</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Wenan Qiang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Wenan Qiang</span></h3>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>c</sup>Department of Obstetrics and Gynecology, Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA</div>
<div class="p">
<sup>d</sup>Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago 60611, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenan Qiang</span></a>
</div>
</div>
<sup>b,</sup><sup>c,</sup><sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Gan Lin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Gan Lin</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>e</sup>Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gan Lin</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almunif%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sultan Almunif</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sultan Almunif</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>f</sup>Bioengineering Institute, King Abdulaziz City for Science and Technology, Riydah 12354, Saudi Arabia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almunif%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sultan Almunif</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharma%20SH%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Swagat H Sharma</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Swagat H Sharma</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharma%20SH%22%5BAuthor%5D" class="usa-link"><span class="name western">Swagat H Sharma</span></a>
</div>
</div>
<sup>a,</sup><sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scariot%20DB%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Debora B Scariot</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Debora B Scariot</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>e</sup>Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scariot%20DB%22%5BAuthor%5D" class="usa-link"><span class="name western">Debora B Scariot</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Junlin Lu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Junlin Lu</span></h3>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>g</sup>Department of Chemical and Biological Engineering, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Junlin Lu</span></a>
</div>
</div>
<sup>b,</sup><sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reichert%20RW%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Robert W Reichert</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Robert W Reichert</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reichert%20RW%22%5BAuthor%5D" class="usa-link"><span class="name western">Robert W Reichert</span></a>
</div>
</div>
<sup>a,</sup><sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Bin Zhang</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Bin Zhang</span></h3>
<div class="p">
<sup>d</sup>Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago 60611, Illinois, USA</div>
<div class="p">
<sup>h</sup>Department of Medicine, Hematology/Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bin Zhang</span></a>
</div>
</div>
<sup>d,</sup><sup>h</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scott%20EA%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Evan A Scott</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Evan A Scott</span></h3>
<div class="p">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div class="p">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div class="p">
<sup>e</sup>Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scott%20EA%22%5BAuthor%5D" class="usa-link"><span class="name western">Evan A Scott</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>e,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="affa">
<sup>a</sup>Department of Biomedical Engineering, Northwestern University, Evanston 60208, Illinois, USA, Email: evan.scott@northwestern.edu</div>
<div id="affb">
<sup>b</sup>Chemistry of Life Processes Institute, Northwestern University, Evanston 60208, Illinois, USA</div>
<div id="affc">
<sup>c</sup>Department of Obstetrics and Gynecology, Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA</div>
<div id="affd">
<sup>d</sup>Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago 60611, Illinois, USA</div>
<div id="affe">
<sup>e</sup>Department of Biomedical Engineering, NanoSTAR Institute, University of Virginia School of Medicine, Charlottesville 22908, Virginia, USA</div>
<div id="afff">
<sup>f</sup>Bioengineering Institute, King Abdulaziz City for Science and Technology, Riydah 12354, Saudi Arabia</div>
<div id="affg">
<sup>g</sup>Department of Chemical and Biological Engineering, Northwestern University, Evanston 60208, Illinois, USA</div>
<div id="affh">
<sup>h</sup>Department of Medicine, Hematology/Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago 60611, Illinois, USA</div>
<div class="author-notes p">
<div class="fn" id="fn2">
<sup>‡</sup><p class="display-inline">S. R. Z. and H. P. contributed equally to this work.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 4; Accepted 2025 Jun 4; Collection date 2025 Aug 21.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>This journal is © The Royal Society of Chemistry</div>
<p>This article is licensed under a <a href="https://creativecommons.org/licenses/by-nc/3.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a>. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12186146  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40552380/" class="usa-link">40552380</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>While monoclonal antibodies have significantly improved cancer treatment, their accumulation in off-target tissues not only limits efficacy, but also induces toxicity. A major contributor to this problem is the mononuclear phagocyte system (MPS). This collection of innate immune cells is a critical regulator of immune homeostasis that effectively scavenges nanoparticles and biologics, preventing their therapeutic effects within solid tumors. Here, pinocytosis inhibitory nanoparticles are demonstrated to safely and temporarily disable the MPS <em>via</em> enhanced delivery of the small molecule actin inhibitor latrunculin A (LatA). This “indirect targeting” strategy is applied to improve anti-programmed death receptor 1 (aPD-1) antibody administration in mice bearing melanoma and colon carcinoma, decreasing aPD-1 interaction with the MPS, avoiding liver toxicity, increasing engagement with target cells, and modulating the immune microenvironment of solid tumors. The resulting change in biodistribution significantly improved safety, anticancer efficacy, and overall survival. Our methodology may be employed to enhance a wide range of monoclonal antibody therapies.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Indirect targeting improves monoclonal antibody biodistribution, safety and efficacy in the treatment of solid tumors.<a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-ga.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/026186f5e9fc/d5nh00206k-ga.jpg" loading="lazy" id="ga" height="320" width="753" alt="graphic file with name d5nh00206k-ga.jpg"></a></p></section><hr class="headless">
<section class="bt xbox font-sm" id="box1"><section id="sec1"><h2 class="pmc_sec_title">New concepts</h2>
<p>Monoclonal antibodies have emerged as an important modality in cancer treatment, boasting superior specificity to chemotherapy and radiation. However, suboptimal biodistribution and unwanted clearance can limit therapeutic antibody efficacy and safety. A major contributor to this is the mononuclear phagocyte system (MPS), a collection of innate immune cells that passively sample the environment around them to maintain homeostasis <em>via</em> a process called pinocytosis, and unfortunately as a result, also scavenge therapeutics. In this work, we employ a strategy called “indirect targeting” using pinocytosis inhibitory nanoparticles to safely and temporarily disable antibody uptake by the MPS, a problem that has largely been overlooked in antibody delivery. This approach was used to ameliorate the biodistribution of the monoclonal antibody anti-programmed death receptor-1 (aPD-1) by decreasing its accumulation in off-target tissues and promoting its engagement with target cells in solid tumors. This enhanced delivery translated to significant improvements in both the efficacy and safety of aPD-1 treatment. Additionally, this strategy does not rely on antigen or tissue-specific features and avoids the need to modify antibody structure or administration, making it a broadly applicable drug delivery strategy.</p></section></section><p>While cancer remains a leading cause of death worldwide, advancements in diagnosis and treatment continue to increase survival rates.<sup><a href="#cit1" class="usa-link" aria-describedby="cit1">1</a></sup> In particular, the development and application of new monoclonal antibody targets and therapeutic strategies in the clinic have yielded remarkable progress.<sup><a href="#cit2" class="usa-link" aria-describedby="cit2">2</a></sup> The bioactivity of these drugs is typically more selective than small molecule chemotherapeutics, which can reduce off-target effects.<sup><a href="#cit3" class="usa-link" aria-describedby="cit3">3</a></sup> However, poor biodistribution and rapid systemic clearance can prevent antibodies from reaching their targets within safe and tolerable ranges of dosage, hindering the usage of new pharmaceutical constructs employing antibodies like antibody–drug conjugates (ADCs) and radiotherapies.<sup><a href="#cit4" class="usa-link" aria-describedby="cit4">4,5</a></sup></p>
<p>Many factors hinder the delivery of therapeutic antibodies. After systemic injection, antibodies exit the vasculature and enter tissues primarily through convection. This process is limited by the large size and hydrophilicity of monoclonal antibodies, and only 5–15 percent of the administered therapeutic distributes from the blood to tissues.<sup><a href="#cit6" class="usa-link" aria-describedby="cit6">6,7</a></sup> In the context of cancer, barriers in the tumor microenvironment (TME) further hinder antibody delivery. Aberrant vasculature, resulting in poor blood flow and vascular permeability, can reduce transport to the site of the tumor. The high hydrostatic pressure and dense extracellular matrix in the TME can physically prevent antibody penetration. Additionally, once at the site of the tumor, the antibody's activity can be hindered by changes in antigen expression, including mutation and downregulation, which limit the ability of the drug to engage with its target. Finally, clearance at the tumor, which occurs <em>via</em> proteolysis after cellular internalization, can further dampen efficacy.<sup><a href="#cit8" class="usa-link" aria-describedby="cit8">8,9</a></sup></p>
<p>The mononuclear phagocyte system (MPS) consists of a broad range of phagocytic cell populations, including macrophages, monocytes and dendritic cells that are spread throughout the body. These cells are important regulators of immune homeostasis and critical modulators of drug delivery and clearance. While passively sampling their surroundings to alert for signs of foreign compounds and danger, they can uptake therapeutics <em>via</em> pinocytosis, limiting target interactions and efficacy.<sup><a href="#cit10" class="usa-link" aria-describedby="cit10">10,11</a></sup> Organs containing concentrated populations of MPS cells overlap with sites of drug off-target accumulation and toxicity, notably the liver, lung, kidney and spleen.<sup><a href="#cit12" class="usa-link" aria-describedby="cit12">12</a></sup> For many pharmaceuticals, including antibody-based therapeutics, the MPS has been proven to have a significant impact on biodistribution and clearance.<sup><a href="#cit11" class="usa-link" aria-describedby="cit11">11,13</a></sup> Thus, the MPS is an additional—and critical—modulator of therapeutic antibody efficacy and safety, and an important consideration in drug delivery.</p>
<p>Previous work to improve antibody delivery has consisted of both active and passive targeting strategies. For example, protein- and glyco-engineering approaches to increase neonatal Fc receptor (FcRn) binding have been shown to prevent antibody catabolism after cellular internalization.<sup><a href="#cit14" class="usa-link" aria-describedby="cit14">14</a></sup> Other attempts have included modifying the isoelectric point of the antibody and increasing affinity for the target antigen, though the latter has not been shown to impact clearance. Changing the amino acid sequence of the antibody can also cause unwanted immunogenicity.<sup><a href="#cit14" class="usa-link" aria-describedby="cit14">14,15</a></sup> For ADCs and radiotherapies, bio-orthogonal chemistry is under investigation for targeting tumor-specific receptors.<sup><a href="#cit16" class="usa-link" aria-describedby="cit16">16</a></sup> In aggregate, these attempts represent efforts to prevent drug clearance and increase half-life, which is correlated with therapeutic efficacy.<sup><a href="#cit17" class="usa-link" aria-describedby="cit17">17</a></sup> Unfortunately, such strategies largely fail to acknowledge the MPS, and a need exists for an orthogonal and broadly applicable method of directly avoiding accumulation of antibody therapeutics within MPS cells and organs.</p>
<p>In this work, we propose employing the strategy of “indirect targeting” to ameliorate therapeutic antibody biodistribution by inhibiting off-target accumulation within the MPS (<a href="#sch1" class="usa-link">Scheme 1</a>).<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18,19</a></sup> Antibody internalization is prevented <em>via</em> the targeted administration of latrunculin A (LatA), a small molecule actin inhibitor that hinders pinocytosis. Our group has previously demonstrated that the pre-administration of LatA-loaded nanoparticles enhances the accumulation of subsequently injected cancer cell-targeted nanoparticles in solid tumors by minimizing their MPS clearance in the liver, spleen, and lymph nodes.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18</a></sup> Here, we investigate this method to improve the delivery and therapeutic efficacy of anti-programmed death receptor-1 (aPD-1), an immune checkpoint inhibitor (ICI) monoclonal antibody that has been employed for the treatment of over 15 different types of cancer.<sup><a href="#cit20" class="usa-link" aria-describedby="cit20">20</a></sup> Initial validation of enhanced solid tumor targeting was performed using B16F10 melanomas. We then assessed therapeutic efficacy in CT26 murine carcinomas, a well-characterized solid tumor model frequently employed to investigate changes in anticancer immunity and tumor growth due to its highly inflamed TME and responsiveness to aPD-1 treatment.<sup><a href="#cit21" class="usa-link" aria-describedby="cit21">21</a></sup> Since LatA is hydrophobic and has poor water solubility, we encapsulated it within nanoparticles consisting of poly(ethylene glycol)-<em>b</em>-poly(propylene sulfide) (PEG-<em>b</em>-PPS), a nontoxic, self-assembling block copolymer with validated utility in drug delivery.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18,22,23</a></sup> Moreover, nanoparticles consisting of PEG-<em>b</em>-PPS are a strong choice for targeting the MPS. The PEG corona of these nanoparticles prevents nonspecific uptake, allowing for selective targeting of phagocytic cells without the need for active targeting strategies.<sup><a href="#cit24" class="usa-link" aria-describedby="cit24">24,25</a></sup> Additionally, the oxidation sensitivity of the block-copolymer promotes nanoparticle disassembly in the lysosome, facilitating intracellular cargo release and the formation of polymer chains small enough to be rapidly cleared by the kidney.<sup><a href="#cit26" class="usa-link" aria-describedby="cit26">26</a></sup> Nanostructure morphology was optimized for MPS targeting, and polymersomes, rather than micelles, were chosen for this work due to their higher systemic stability and accumulation within cells of the MPS.<sup><a href="#cit27" class="usa-link" aria-describedby="cit27">27</a></sup></p>
<figure class="fig xbox font-sm" id="sch1"><h2 class="obj_head">Scheme 1. Overview of the “indirect targeting” strategy for improving monoclonal antibody accumulation and efficacy in solid tumors <em>via</em> priming with latrunculin-A-loaded polymersome (LatA-PS) injections.</h2>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-s1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/f9558e5d7add/d5nh00206k-s1.jpg" loading="lazy" height="373" width="772" alt="Scheme 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>In this proof-of concept work, we found that indirect targeting can limit aPD-1 uptake by the MPS and increase its interaction with T cells. Importantly, we show that LatA can generate significant enhancements in the anticancer efficacy, while meaningfully reducing the systemic toxicity, generated by aPD-1.<sup><a href="#cit28" class="usa-link" aria-describedby="cit28">28,29</a></sup> Both <em>in vitro</em> and <em>in vivo</em> results show encapsulation within nanocarriers was necessary to avoid toxicity of free form LatA. Given it is antigen- and tissue-agonistic and that our pre-injection protocol avoids the need to modify the formulation or administration of the monoclonal antibody, we believe these pinocytosis inhibitory nanoparticles can improve the delivery of a wide variety of therapeutic antibodies across tumor-type and disease indication to have a significant clinical impact.</p>
<section id="sec2"><h2 class="pmc_sec_title">Results and discussion</h2>
<section id="sec3"><h3 class="pmc_sec_title">Characterization of LatA-PS</h3>
<p>LatA-loaded polymersomes (LatA-PS) were formed from the self-assembly of methoxy poly(ethylene glycol)-<em>b</em>-poly(propylene sulfide)-benzyl (mPEG<sub>17</sub>-PPS<sub>30</sub>-Bz) <em>via</em> thin film hydration as previously described.<sup><a href="#cit23" class="usa-link" aria-describedby="cit23">23</a></sup> Polymer purity was confirmed with <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy and gel permeation chromatography (GPC) (Fig. S1, ESI<a href="#fn1" class="usa-link">†</a>). Cryogenic-transmission election microscopy (cryo-TEM) and small angle X-ray scattering (SAXS) confirmed the vesicular nanoparticle morphology (<a href="#fig1" class="usa-link">Fig. 1A and B</a>). Dynamic light scattering was used to determine the <em>z</em>-average, polydispersity and zeta potential of LatA-PS, which were 97.0 nm, 0.24, and −3.8 mV respectively (Fig. S2, ESI<a href="#fn1" class="usa-link">†</a>). Particle diameter and membrane thickness were also determined by SAXS, which were estimated to be 65.0 nm, and 9.5 nm, respectively (Fig. S2B, ESI<a href="#fn1" class="usa-link">†</a>). LatA loaded well within the nanoparticles, with an encapsulation efficiency of 45.8 percent, as determined by reverse-phase high performance liquid chromatography (RP-HPLC, Fig. S2B, ESI<a href="#fn1" class="usa-link">†</a>).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Fig. 1. Material characterization and effects of latrunculin A-loaded polymersomes (LatA-PS) <em>in vitro</em>. Vesicular polymersome morphology for LatA-PS was verified by (A) cryogenic transmission electron microscopy (<em>n</em> = 3) and (B) small angle X-ray scattering (SAXS, <em>n</em> = 2). Cytotoxicity and cell proliferation of (C) RAW 264.7 macrophages and (D) CT26 cells after 24 h in culture with free LatA or LatA-PS was assessed using an MTT assay (<em>n</em> = 3). (E) RAW 264.7 macrophages treated with LatA-PS for 24 h and then stained with NucBlue<sup>TM</sup> and AlexaFluour<sup>TM</sup> 488-Phalloidin were imaged with confocal microscopy (<em>n</em> = 3) scale bar represents 10 μm. (F) Mean fluorescence intensity (MFI) of RAW 264.7 macrophages treated with LatA-PS for 24 h and then Flamma® Fluors 648-labeled-aPD-1 for 2 h (<em>n</em> = 3). (G) Representative confocal microscopy of RAW 264.7 macrophages treated with LatA for 30 min and then incubated with Flamma® Fluors 648-labeled aPD-1 for 15 min demonstrated decreased aPD-1 uptake (<em>n</em> = 3 technical replicates, <em>n</em> = 1 biological replicate). Scale bar represents 50 μm. All data are reported as mean ± sd, * <em>p</em>-value &lt; 0.05, ** <em>p</em>-value &lt; 0.01, *** <em>p</em>-value &lt; 0.001, **** <em>p</em>-value &lt; 0.001 (ANOVA).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/d81604ea5ab6/d5nh00206k-f1.jpg" loading="lazy" height="310" width="797" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec4"><h3 class="pmc_sec_title">LatA-PS are potent actin inhibitors <em>in vitro</em>
</h3>
<p>
<em>In vitro</em> studies were performed to determine the cellular effects of LatA and LatA-PS. Since LatA, an inhibitor of actin polymerization, is known to be cytotoxic at high concentrations, viability studies were completed.<sup><a href="#cit30" class="usa-link" aria-describedby="cit30">30</a></sup> For this, an MTT assay was performed on both RAW 264.7 macrophages (<a href="#fig1" class="usa-link">Fig. 1C</a>) and CT26 cells (<a href="#fig1" class="usa-link">Fig. 1D</a>), which were incubated with free LatA or LatA-PS for 24 h. Flow cytometry was also performed to assess viability on RAW 264.7 macrophages (Fig. S3, ESI<a href="#fn1" class="usa-link">†</a>). Untreated cells were used as a control. The effect of LatA on cell viability was concentration dependent. Additionally, polymersome encapsulation significantly reduced LatA toxicity, consistent with past findings regarding LatA-micelle encapsulation.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18</a></sup></p>
<p>After showing polymersome encapsulation mitigates LatA's known cytotoxicity, the ability of LatA-PS to affect actin polymerization was investigated. RAW 264.7 macrophages were incubated with either LatA-PS or PBS, stained with NucBlue<sup>TM</sup> and AlexaFluour<sup>TM</sup> 488-Phalloidin, a dye that binds actin filaments (F-actin), and imaged with confocal microscopy (<a href="#fig1" class="usa-link">Fig. 1E</a>).<sup><a href="#cit31" class="usa-link" aria-describedby="cit31">31</a></sup> Untreated cells displayed expansive actin networks throughout the cell, while those treated with LatA-PS had less F-actin present, indicating interference with actin polymerization. Additionally, cells incubated with LatA-PS had a rounded, rather than spindle-like, morphology, further suggesting that LatA affected the actin cytoskeleton.<sup><a href="#cit31" class="usa-link" aria-describedby="cit31">31,32</a></sup></p>
<p>LatA has been previously shown to decrease nanoparticle uptake by inhibiting macropinocytosis, which occurs in as little as 30 min and maintains peak efficacy for greater than one hour after drug removal (Fig. S4, ESI<a href="#fn1" class="usa-link">†</a>). However, its influence on antibody uptake; which can occur through multiple receptor-dependent and independent pathways including antigen-binding, Fc receptor (FcR) binding and pinocytosis; had yet to be determined.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18,33</a></sup> To investigate this, RAW 264.7 macrophages were treated, or primed, with LatA-PS or PBS for 24 h and then incubated with Flamma® Fluors 648-labeled-aPD-1 for 2 h. Remaining aPD-1 in solution was washed away, and the amount of aPD-1 engaged with cells was determined by fluorescence (<a href="#fig1" class="usa-link">Fig. 1F</a>). Cells treated with LatA-PS were found to have significantly less aPD-1 interaction, decreasing mean fluorescent intensity (MFI) by up to 4.3-fold. Inhibition of cellular uptake was confirmed by confocal microscopy. RAW 264.7 cells were primed with LatA for 30 min, treated with Flamma® Fluors 648-labeled-aPD-1 for 15 min, and stained with NucBlue<sup>TM</sup>. Confocal revealed a lower number of cells positive for aPD-1 upon treatment with LatA-PS (<a href="#fig1" class="usa-link">Fig. 1G</a>). Collectively, these results demonstrate that LatA can block the cellular internalization of aPD-1 by relevant cells within the MPS.</p></section><section id="sec5"><h3 class="pmc_sec_title">LatA-PS priming facilitates indirect targeting of tumors <em>in vivo</em>
</h3>
<p>To determine if LatA-PS priming could promote indirect targeting of tumors, enhancing therapeutic antibody accumulation in tumor tissue and reducing uptake in MPS organs, mice bearing melanoma were treated with free LatA or LatA-PS and Flamma® Fluors 648-labeled-aPD-1 (<a href="#fig2" class="usa-link">Fig. 2</a>). Briefly, C57BL/6 mice were injected subcutaneously with 5 × 10<sup>5</sup> B16F10 cells and tumors were allowed to grow to 100 mm<sup>3</sup>. Mice received two 7 μM injections of either free LatA or LatA-PS at 24 h and 4 h prior to aPD-1 administration, according to an established dosing regimen.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18</a></sup> Mice then received a single 100 μg injection of Flamma® Fluors 648-labeled-aPD-1. Untreated mice and mice receiving only aPD-1 were used as controls. An <em>in vivo</em> imaging system (IVIS) was employed to measure aPD-1 uptake, with the imaging angle optimized to visualize aPD-1 tumor accumulation in real time. At 2 days-post aPD-1 injection, mice were sacrificed and aPD-1 uptake in the heart, lung, spleen, liver, kidney and tumor, were assessed <em>ex vivo</em> (<a href="#fig2" class="usa-link">Fig. 2A</a>). Total radiant efficiency was calculated for each organ using the Living Image<sup>TM</sup> software.</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">Fig. 2. Effect of LatA on organ-level biodistribution of aPD-1 in a murine melanoma model. (A) Mice bearing subcutaneous B16F10 tumors were administered two 7 μm injections of free LatA or LatA-PS 24 h (−24 h) and again 4 h (−4 h) prior to injection of 100 μg of Flamma® Fluors 648-labeled aPD-1. Untreated mice were used as controls. Mice were monitored with IVIS and sacrificed 2 days after the aPD-1 injection. (B) Representative <em>ex vivo</em> images of various tissues and (C) quantification are shown for aPD-1 accumulation in various tissues (<em>n</em> = 3–5). All data are reported as mean ± sd, * <em>p</em>-value &lt; 0.05, ** <em>p</em>-value &lt; 0.01 (ANOVA, see section Statistical analysis).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/acaa39894346/d5nh00206k-f2.jpg" loading="lazy" height="1600" width="781" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>IVIS imaging showed LatA priming to significantly increase aPD-1 accumulation in the tumor over the course of 2 days post-injection (<a href="#fig2" class="usa-link">Fig. 2B, C</a> and Fig. S5, ESI<a href="#fn1" class="usa-link">†</a>). That is, pre-administration of free LatA or LatA-PS increased the aPD-1 signal 7-fold and 5.4-fold, compared to aPD-1 injection alone, respectively (<a href="#fig2" class="usa-link">Fig. 2C</a>). This increase in tumor accumulation might be attributed at least in part to decreased MPS uptake, which can promote antibody clearance, and may have allowed more aPD-1 to circulate and reach target tissues.<sup><a href="#cit11" class="usa-link" aria-describedby="cit11">11,13</a></sup> Altogether, these results suggest that LatA priming allows for the indirect targeting of tumors, by promoting accumulation in the TME.</p></section><section id="sec6"><h3 class="pmc_sec_title">LatA-PS priming promotes indirect targeting of aPD-1 on a cellular-level</h3>
<p>We anticipated that the shift in organ-level biodistribution of aPD-1 would be accompanied by changes at the cellular level. To test this, mice bearing colon carcinoma were treated with Flamma® Fluors 648-labeled-aPD-1 in the presence or absence of free LatA or LatA-PS (<a href="#fig3" class="usa-link">Fig. 3</a>). A CT26, rather than B16F10, model was selected for cellular-level antibody biodistribution, immunomodulation and tumor growth inhibition experiments due to the CT26 model's increased immune infiltration and PD-L1 expression in the TME, which confer better responsiveness to ICIs.<sup><a href="#cit34" class="usa-link" aria-describedby="cit34">34,35</a></sup> Additionally, since we only sought to change the biodistribution of the therapeutic antibody, rather than its mechanism of action, choosing a model already well-established to respond to aPD-1 treatment was paramount. Briefly, mice were injected subcutaneously with 2 × 10<sup>5</sup> CT26 cells and began treatment when tumor volumes reached approximately 120 mm<sup>3</sup>. Mice receiving treatment were administered 10 mg kg<sup>−1</sup> aPD-1 three times, once every 3 days. Mice primed with LatA received either 7 μM free LatA or LatA-PS injections at both 24 h and 4 h prior to each aPD-1 administration (<a href="#fig3" class="usa-link">Fig. 3A</a>). Untreated mice were used as controls. Mice were sacrificed 24 h after the final aPD-1 injection and flow cytometry was performed to determine the cellular biodistribution of aPD-1 in the tumor. Changes in the anticancer immune response were also analyzed in the tumor and spleen.</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">Fig. 3. Effect of LatA on cellular-level biodistribution of aPD-1 in a colon carcinoma model. Mice bearing subcutaneous CT26 tumors were treated with Flamma® Fluors 648-labeled aPD-1 at 10 mg kg<sup>−1</sup> with or without 7 μm free LatA or LatA-PS. (A) Mice received three aPD-1 injections, separated by 3 days. LatA injections were given 24 h (−24 h) and 4 h (−4 h) prior to each aPD-1 injection. Untreated mice were used as controls. Mice were sacrificed 24 h after the final injection or at efficacy endpoints and flow cytometry of tumor tissue was performed (B–E, <em>n</em> = 5–6) and tumor tissues were stained (F–I, <em>n</em> = 3). aPD-1 engagement with (B) CD11b positive cells and (C) CD3 positive cells in the tumor. (D) PD-1 expression on CD3 positive cells in the spleen. (E) CD163 expression on CD11b positive F4/80 cells in the tumor. (F) CD3 (G) CD11c and (H) MHC II expression in the TME. (I) Representative immunofluorescence images of tumor sections. Scale bar represents 200 μm. All data are reported as mean ± sd, * <em>p</em>-value &lt; 0.05, ** <em>p</em>-value &lt; 0.01 (ANOVA, see section Statistical analysis).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/7706c21e6e9a/d5nh00206k-f3.jpg" loading="lazy" height="1019" width="730" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Since highly phagocytic cells can scavenge therapeutic antibodies, aPD-1 was expected to co-localize with myeloid cells in the TME.<sup><a href="#cit36" class="usa-link" aria-describedby="cit36">36</a></sup> Indeed, there was a distinct CD11b positive population in the tumor positive for Flamma® Fluors 648-labeled-aPD-1 by flow cytometry (Fig. S6A, ESI<a href="#fn1" class="usa-link">†</a>). This CD11b positive cell engagement was lower in response to LatA priming, presumably due to inhibition of antibody uptake. This decline was significant in mice treated with LatA-PS, which reduced engagement 2-fold (<a href="#fig3" class="usa-link">Fig. 3B</a>). Importantly, the decline in myeloid cell uptake was accompanied by an increase in target cell engagement. While PD-1 is expressed on a variety of cell types, T cells are considered to be the main driver of aPD-1's therapeutic activity.<sup><a href="#cit37" class="usa-link" aria-describedby="cit37">37,38</a></sup> LatA-PS priming significantly boosted the number of T cells in the tumor engaged with Flamma® Fluors 648-labeled-aPD-1, from 2.3 percent to 6.3 percent (<a href="#fig3" class="usa-link">Fig. 3C</a> and Fig. S6B, ESI<a href="#fn1" class="usa-link">†</a>). This can likely be attributed to the increased aPD-1 tumor accumulation (<a href="#fig2" class="usa-link">Fig. 2B and C</a>), which would facilitate and increase T cell binding. The effect of LatA on the cellular-level biodistribution of aPD-1 was greatly enhanced by polymersome encapsulation. Since nanoparticles have increased uptake by the MPS, it is likely that LatA-PS more effectively targeted MPS cells than free LatA.<sup><a href="#cit39" class="usa-link" aria-describedby="cit39">39</a></sup> More efficient disabling of the system then resulted in greater changes in aPD-1 biodistribution. Overall, these results demonstrate that indirect targeting ameliorates both the organ-level and cellular-level biodistribution of aPD-1.</p></section><section id="sec7"><h3 class="pmc_sec_title">Indirect targeting enhances the anticancer immune response initiated by aPD-1</h3>
<p>The decreased MPS uptake, increased tumor accumulation and elevated T cell engagement of aPD-1 translated to improvements in anticancer immunity. Flow cytometry indicated mice treated with aPD-1 monotherapy experienced lower levels of PD-1 expression on T cells in the spleen, suggesting less T cell exhaustion. These differences were only significant when combined with free LatA or LatA-PS (<a href="#fig3" class="usa-link">Fig. 3D</a>).<sup><a href="#cit38" class="usa-link" aria-describedby="cit38">38</a></sup> As in the case of the T cell response, the innate immune response in the TME was heightened with indirect targeting. Flow cytometry indicated that there were ∼35 percent less CD163 positive macrophages in the tumor in response to LatA-PS priming (<a href="#fig3" class="usa-link">Fig. 3E</a>). Free LatA priming resulted in a similar decline in the percent of CD163 positive macrophages, though this trend was not significant. CD163 is an important marker of macrophage polarization, indicating a more regenerative, less inflammatory phenotype.<sup><a href="#cit40" class="usa-link" aria-describedby="cit40">40</a></sup> Thus, lower, levels of CD163 positive macrophages suggests a more anti-cancer immune microenvironment. No significant differences from the untreated control were observed in mice that received the aPD-1 monotherapy alone.</p>
<p>To determine if the immune response was maintained over time, a second set of mice were treated with the same injection regimen and were sacrificed when tumor volumes reached 1000 mm<sup>3</sup> or at 40 days-post treatment initiation. The tumors were harvested, sectioned and stained for various markers. The tumor sections of these mice revealed significantly higher T cell infiltration in response to LatA-PS priming (<a href="#fig3" class="usa-link">Fig. 3F, I</a> and Fig. S7, ESI<a href="#fn1" class="usa-link">†</a>). Specifically, the CD3 signal in the tumor increased 3.2-, 8.5- and 6.3-fold in response to LatA-PS priming, compared to the free LatA-priming, aPD-1 monotherapy, or no treatment, respectively. Mice at efficacy endpoints also had a stronger myeloid cell presence in tumor tissues. Indirect targeting augmented CD11c expression in the TME (<a href="#fig3" class="usa-link">Fig. 3G, I</a>, and Fig. S8, ESI<a href="#fn1" class="usa-link">†</a>). That is, tumor tissues of mice primed with LatA-PS and treated with aPD-1, exhibited significantly higher CD11c expression than those of other groups, with an increase in MFI of over 25-fold for the LatA-PS group compared to all other groups. The CD11c positive cells appeared absent in some groups, as their presence was minimal in comparison to the strong CD11c signal in the LatA-PS primed group. Increasing the intensity of the CD11c group allows these cells to be more easily visualized but saturates the signal in the LatA-PS group (Fig. S8, ESI<a href="#fn1" class="usa-link">†</a>). Differences in MHC II levels in the TME were similarly dramatic, with LatA-PS priming significantly increasing MHC II levels the TME 4.2- to 6.6-fold compared to all other groups (<a href="#fig3" class="usa-link">Fig. 3H, I</a> and Fig. S8, ESI<a href="#fn1" class="usa-link">†</a>). Collectively, these results indicate that indirect targeting enhances the anticancer immune response initiated by aPD-1 in a robust manner.</p></section><section id="sec8"><h3 class="pmc_sec_title">Indirect targeting enhances tumor growth inhibition in colon carcinoma</h3>
<p>Since indirect targeting was found to improve aPD-1's accumulation in the tumor, engagement with T cells, and anticancer immune response, we anticipated it would also have a significant effect on tumor growth. To investigate this, mice were treated with the therapeutic dosing regimen described previously and tumors were allowed to grow until a volume of 1000 mm<sup>3</sup> or until 40 days after treatment initiation (<a href="#fig4" class="usa-link">Fig. 4A</a>). We found that the anticancer efficacy of aPD-1, which had only a small impact on tumor growth inhibition when used alone, was enhanced with LatA priming. On day 8, the average tumor size of mice that received free LatA or LatA-PS were similar, paralleling the similar aPD-1 organ-level biodistribution results seen in <a href="#fig2" class="usa-link">Fig. 2</a> These tumors were significantly smaller than untreated mice, with 46.5 and 49.8 percent decreases in tumor volume, respectively (<a href="#fig4" class="usa-link">Fig. 4B, C</a> and Fig. S9A, ESI<a href="#fn1" class="usa-link">†</a>). This reduction in tumor volume in the LatA-PS group was also significant compared to the aPD-1 monotherapy group, with a 40.9 percent reduction in tumor volume comparatively. Furthermore, some mice treated with LatA-PS not only had slower growth, but also experienced reductions in tumor volume, a phenomenon that was not observed in any other group (<a href="#fig4" class="usa-link">Fig. 4C</a>). The dynamics of tumor growth were confirmed on a cellular level, as the tumors of mice treated with aPD-1, with or without LatA priming, exhibited less Ki67 expression (<a href="#fig4" class="usa-link">Fig. 4D</a> and Fig. S9B, ESI<a href="#fn1" class="usa-link">†</a>). Ki67 is a marker of cellular proliferation, and thus tumors with lower Ki67 expression experienced slower growth. This difference was significant between the LatA-PS primed group and the untreated control, with a 27.5-fold decrease in MFI. Importantly, slower tumor growth translated to increased survival (<a href="#fig4" class="usa-link">Fig. 4E</a>). Treatment with aPD-1 alone had a weak impact on survival, increasing median survival time from 9 to 11 days. The addition of free LatA or LatA-PS increased median survival time to 19.5 and 26.5 days, respectively, a significant improvement compared to the untreated and monotherapy groups. Notably, the LatA-PS group had significantly better survival than the free LatA group. This is consistent with the previous results showing polymersome encapsulation enhances LatA activity by increasing the engagement of aPD-1 with CD3 positive cells in the tumor (<a href="#fig3" class="usa-link">Fig. 3C</a>). Additionally, the treatment was well-tolerated, with no significant changes in body weight observed during dosing (Fig. S9C, ESI<a href="#fn1" class="usa-link">†</a>). Collectively, this data demonstrates that LatA priming can ameliorate the antitumor effects of aPD-1 and that indirect targeting is a promising strategy for improving therapeutic antibody efficacy.</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">Fig. 4. Anticancer effect and safety of LatA and aPD-1 combination therapy on colon cancer <em>in vivo</em>. (A) Mice bearing subcutaneous CT26 tumors were divided into 4 groups and treated with either PBS, aPD-1, free LatA and aPD-1, or LatA-PS and aPD-1. aPD-1 injections were given at 10 mg kg<sup>−1</sup>, once every 2 days for a total of three injections. Free LatA and LatA-PS injections occurred 24 h prior (−24 h) and again 4 h (−4 h) prior to each aPD-1 injection at a concentration of 7 μm. (B) Average tumor growth and over a period of 8 days (<em>n</em> = 8–14). (C) Individual tumor growth curves through day 40 post-treatment or until tumor volume exceeded 1000 mm<sup>3</sup>. (D) Ki67 expression levels in tumor tissues (<em>n</em> = 3). (E) Survival of mice out to 40 days (<em>n</em> = 8–14). (F) Representative images of H&amp;E staining of major organs (<em>n</em> = 3 technical replicates, <em>n</em> = 2 biological replicates). Scale bar represents 50 μm. All data are reported as mean ± sd, * <em>p</em>-value &lt; 0.05, ** <em>p</em>-value &lt; 0.01 (ANOVA, see section Statistical analysis).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12186146_d5nh00206k-f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/4cb52d428a1b/d5nh00206k-f4.jpg" loading="lazy" height="792" width="780" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Enhancing the activity of aPD-1 has important clinical implications. Perhaps the most significant consequence is that increasing the efficacy of a drug generally improves outcomes for the patient. Additionally, greater therapeutic activity could allow for reductions in dose, which can have several benefits. First, lowering the concentration of a pharmaceutical can reduce the likelihood and/or severity of adverse events that may lead to treatment discontinuation and failure in clinical trials.<sup><a href="#cit29" class="usa-link" aria-describedby="cit29">29,41,42</a></sup> Second, dosing frequency may be reduced, which can increase patient compliance and decrease healthcare costs, especially for therapeutics that require intravenous infusion.<sup><a href="#cit43" class="usa-link" aria-describedby="cit43">43</a></sup> Third, lower doses can increase affordability and accessibility of treatment. Thus, achieving enhanced therapeutic antibody efficacy with indirect targeting can be a tremendous benefit to the healthcare ecosystem.</p></section><section id="sec9"><h3 class="pmc_sec_title">LatA-PS increases safety of treatment <em>in vivo</em>
</h3>
<p>The safety of indirect targeting was further assessed with histological analysis. While no mice exhibited significant changes in body weight during treatment (Fig. S9C, ESI<a href="#fn1" class="usa-link">†</a>), hematoxylin and eosin (H&amp;E) staining of major organs indicated signs of toxicity for several groups receiving aPD-1. As broad disrupters of immune homeostasis, this is unfortunately common for ICIs. No signs of toxicity were noted in untreated mice (<a href="#fig4" class="usa-link">Fig. 4F</a> and Fig. S9D, ESI<a href="#fn1" class="usa-link">†</a>). Lymphocyte infiltration was seen in the livers of mice treated with aPD-1 alone, a phenomenon previously observed in response to ICI administration. The signs of toxicity apparent in the liver were intensified in mice primed with free LatA. Significant lymphocyte infiltration was observed in these tissues, as were signs of a hemorrhage, indicated by notable red blood cell accumulation in the tissue. While the aPD-1 monotherapy group also had red blood cell infiltration in the liver, only the change seen in the free LatA group is definitively pathological. The kidneys of mice primed with free LatA also showed signs of inflammation, with lymphocytes pooled in the left half of one of the glomeruli. Additionally, the spleens of these mice exhibited disrupted histoarchitecture. The follicular organization is disturbed, likely due to the presence of rapidly dividing immune cells resulting from aggressive inflammation.<sup><a href="#cit44" class="usa-link" aria-describedby="cit44">44</a></sup> LatA can be cytotoxic at high concentrations due to its interference with actin polymerization and is under investigation as an experimental chemotherapy since it can prevent cell division.<sup><a href="#cit45" class="usa-link" aria-describedby="cit45">45</a></sup> It is possible that since free LatA is toxic, it directly killed cells in the liver, kidney and spleen, and cell death contributed to the observed inflammation.<sup><a href="#cit46" class="usa-link" aria-describedby="cit46">46</a></sup></p>
<p>The tissues of mice primed with LatA-PS lacked the signs of toxicity observed in those primed with free LatA. This difference is unlikely to be attributed solely to the subsequent aPD-1 injection, as LatA-PS resulted in lower aPD-1 accumulation in the liver than free form LatA, but not in the kidney and spleen (<a href="#fig2" class="usa-link">Fig. 2B and C</a>). It is possible that this mitigated inflammation may be due to decreased LatA cytotoxicity upon polymersome encapsulation. Nanoparticle formulations can decrease the toxicity of free drugs, which was observed with LatA <em>in vitro</em> (<a href="#fig1" class="usa-link">Fig. 1C and D</a>) and is consistent with our prior work using LatA-loaded nanocarriers.<sup><a href="#cit22" class="usa-link" aria-describedby="cit22">22,47,48</a></sup></p>
<p>Incredibly, LatA-PS also reduced the toxicity associated with aPD-1. Hepatotoxicity is a known response to ICI treatment and is presumed to be due to a loss of self-tolerance.<sup><a href="#cit28" class="usa-link" aria-describedby="cit28">28</a></sup> Murine models of ICI-related toxicity have implicated both T cells and myeloid cells in the liver inflammation.<sup><a href="#cit29" class="usa-link" aria-describedby="cit29">29</a></sup> Depletion of macrophages with clodronate liposomes has been shown to prevent anti-CD40-induced liver damage, suggesting the MPS plays a causal role in ICI-related hepatotoxicity.<sup><a href="#cit49" class="usa-link" aria-describedby="cit49">49</a></sup> In this work, we see a similar decrease in liver inflammation with indirect targeting, where LatA-PS priming seemingly reduces the liver toxicity in response to aPD-1 treatment. However, unlike clodronate liposomes, indirect targeting safely and temporarily disables pinocytosis without eliminating an entire cell population and broadly disrupting the immune microenvironment.<sup><a href="#cit50" class="usa-link" aria-describedby="cit50">50</a></sup></p>
<p>The differences in toxicity observed in the liver may be the result of both organ- and cellular-level changes. It is possible that LatA-PS priming resulted in lower aPD-1 liver accumulation, which subsequentially decreased aPD-1-mediated toxicity (<a href="#fig2" class="usa-link">Fig. 2</a>). Moreover, since ICIs can disrupt immune homeostasis, the resulting small modulations of immune cells can expand and propagate into wide ranging and often toxic effects. Depending on the immune mechanisms involved, these changes may not correlate directly with the concentration of aPD-1 in specific organs. These effects likely involve complex inflammatory pathways instead of direct cell killing and toxicity observed for chemotherapies.<sup><a href="#cit13" class="usa-link" aria-describedby="cit13">13,28</a></sup> Additionally, LatA may affect processes such as antigen presentation and receptor cycling, which rely on actin polymerization and modulate inflammatory responses.<sup><a href="#cit51" class="usa-link" aria-describedby="cit51">51–53</a></sup> The impact of indirect targeting on aPD-1 safety has important clinical implications, and additional work should be performed to elucidate how LatA-PS affect aPD-1-mediated off-target toxicity.</p>
<p>Compared to previously reported strategies, indirect targeting has the benefit of improving both therapeutic efficacy and safety without the need to modify antibody structure.<sup><a href="#cit54" class="usa-link" aria-describedby="cit54">54</a></sup> Antibody engineering can cause unwanted immunogenicity, which can result from changing the amino acid sequence, using nonmammalian cells for glycoengineering, or employing certain antibody drug conjugate linker methods. Furthermore, these approaches may decrease the affinity of the antibody for its intended target.<sup><a href="#cit14" class="usa-link" aria-describedby="cit14">14,55</a></sup> Changing the antibody structure can also be a cumbersome process, as a new design, in addition to screening, optimization and validation, is required for each target. Here, we describe an approach that employs a distinct stand-alone LatA-PS formulation, which avoids the need to modify the subsequently injected therapeutic antibody for improved delivery and efficacy, which may facilitate clinical translation. Additionally, its lack of reliance on antigen- or tissue-specific features, makes indirect targeting broadly applicable to other antibody-based therapeutics. As such, an interesting next testbed for this approach might be in ADC treatment, which can be severely limited by off-target toxicity. For example, indirect targeting can potentially reduce off-target chemotherapy uptake resulting from payload deconjugation or ADC uptake <em>via</em> pinocytosis, two processes that contribute to off-target toxicity.<sup><a href="#cit13" class="usa-link" aria-describedby="cit13">13</a></sup></p>
<p>To further enhance the clinical relevance of the indirect targeting platform, additional injection regimes can be explored. The time points and route of administration selected here were based on an established scheme to ameliorate nanoparticle delivery. In the previous work, two dosing schedules were tested.<sup><a href="#cit18" class="usa-link" aria-describedby="cit18">18</a></sup> The first had a 24 h and 4 h pre-injection of LatA prior to the effector nanoparticle administration. The other platform had a 24 h pre-injection of LatA followed by a co-injection of LatA with the effector nanoparticle. Here, we chose to match the 24 h and 4 h pre-injection regimen. PEG-<em>b</em>-PPS polymersome accumulation is noticeable in MPS tissues such as the liver, kidney and spleen in as little as 1 h after intravenous injection and continues to have significant accumulation through at least 48 h.<sup><a href="#cit27" class="usa-link" aria-describedby="cit27">27</a></sup> We wanted to ensure the nanoparticles had sufficient time to accumulate and exert their effects on macropinocytosis before administering the antibody. Additionally, the effects of LatA on endocytosis inhibition start in as little as 30 min and begin to wane between 1 and 2 h <em>in vitro</em>, but still have significant effects for at least 2 h (Fig. S4, ESI<a href="#fn1" class="usa-link">†</a>).<sup><a href="#cit27" class="usa-link" aria-describedby="cit27">27</a></sup> Thus, we hypothesized that the established pre-treatment strategy would have a positive effect on aPD-1 biodistribution. As this work is a proof-of-concept demonstrating the impact of LatA priming on aPD-1 therapeutic activity, additional dosing regimens were not evaluated. Exploring a co-injection strategy, in which LatA and aPD-1 are administered simultaneously, may be more translatable to the clinic, as it would require fewer intravenous infusions. Instead of using the intravenous route, more easily administered subcutaneous injections of LatA might also be of benefit for clinical translation. Regardless, this work highlights the ability of indirect targeting to improve both the safety and efficacy of aPD-1 administration.</p></section></section><section id="sec10"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In this work, a new indirect targeting strategy was developed to enhance the delivery of therapeutic antibodies to solid tumors. Priming with pinocytosis inhibitory LatA-PS was shown to improve the biodistribution of aPD-1 by decreasing accumulation within the MPS, enhancing tumor accumulation, and increasing interaction with T cells. This change in biodistribution translated to meaningful benefits in the anticancer immune response and tumor growth inhibition initiated by aPD-1. Furthermore, this approach improved the safety of aPD-1 by minimizing its off-target toxicity. This enhanced efficacy and reduced off-target toxicity may result in many benefits in the clinic, including better prognosis, fewer adverse events, less frequent dosing, greater patient compliance and lower cost.<sup><a href="#cit41" class="usa-link" aria-describedby="cit41">41,43,56</a></sup> Given its ability to augment both efficacy and safety, antigen- and tissue-agonistic approach, and capacity to complement other targeting strategies, we anticipate that indirect targeting <em>via</em> LatA-PS will improve a wide variety of therapeutic antibodies across solid tumors and for diverse disease indications.</p></section><section id="sec11"><h2 class="pmc_sec_title">Experimental sections</h2>
<section id="sec12"><h3 class="pmc_sec_title">Study design</h3>
<p>The goal of this work was to determine how changing the biodistribution of aPD-1 to prevent its uptake by the MPS affected its anticancer response. To do this, we formed LatA-loaded nanoparticles to inhibit the MPS. We explored their effect on actin polymerization and aPD-1 cellular uptake <em>in vitro</em>, and how they change aPD-1 organ- and cellular level biodistribution <em>in vivo</em>. We investigated their ability to enhance aPD-1's anticancer immune response and tumor growth inhibition. Finally, we evaluated the toxicity of the approach.</p></section><section id="sec13"><h3 class="pmc_sec_title">Materials</h3>
<p>LatA and was Phalloidin-iFluor™ 488 Conjugate were purchased from Cayman Chemicals. Anti-Mouse PD-1 (CD279) Rat Monoclonal Antibody [RMP1–14] was purchased from Bio X Cell. Flamma® Fluors 648 was purchased from BioActs. Zeba spin desalting columns, NucBlue<sup>TM</sup> and dialysis cassettes were purchased from ThermoFisher. DMEM was purchased from Gibco. Collagenase III and liberase TH and were purchased from Worthington Biomedical and Roche, respectively. Zombie live/dead, red blood cell lysis buffer, cell staining buffer, fluorescent antibodies and cell fixation buffer were purchased from BioLegend. All other chemicals were purchased from Sigma-Aldrich.</p></section><section id="sec14"><h3 class="pmc_sec_title">Cell culture</h3>
<p>Murine colon carcinoma CT26 cells, melanoma B16F10 cells, and RAW 264.7 macrophages were purchased from ATCC. CT26 and DC2.4 cells were cultured in complete media, consisting of RMPI 1640 with 10% FBS, 100 U mL<sup>−1</sup> and 100 μg mL<sup>−1</sup> streptomycin. Murine B16F10 cells and RAW 264.7 macrophages cells were purchased from ATCC. Raw 264.7 cells were cultured in DMEM media with 10% FBS, 100 U mL<sup>−1</sup> and 100 μg mL<sup>−1</sup> streptomycin. Cells were utilized in experiments during the logarithmic growth phase.</p></section><section id="sec15"><h3 class="pmc_sec_title">Animals</h3>
<p>Female C57BL/6 mice (6–8 weeks old) were purchased from Jackson Laboratories. Male Balb/c mice (6–8 weeks old) were purchased from Jackson Laboratories. All animal experiments were conducted in accordance with the guidelines and regulations approved by the Laboratory Animal Welfare and Ethics Committee of Northwestern University (Approved Protocol Numbers: IS00017606 and IS00007992).</p></section><section id="sec16"><h3 class="pmc_sec_title">Synthesis and characterization PEG-<em>b</em>-PPS-Bz</h3>
<p>PEG<sub>17</sub>-<em>b</em>-PPS<sub>30</sub>-Bz was synthesized according to established procedures.<sup><a href="#cit26" class="usa-link" aria-describedby="cit26">26</a></sup> Methyl ether PEG was functionalized with a mesylate group <em>via</em> the addition of sodium hydroxide and methanesulfonyl chloride. PEG mesylate was then used to generate PEG thioacetate. Finally, PEG thioacetate was used to initiate the living polymerization of propylene sulfide, which was end capped with benzyl bromide. <sup>1</sup>H NMR spectroscopy and GPC were used to characterize the synthesized polymer.</p></section><section id="sec17"><h3 class="pmc_sec_title">Preparation of polymersomes by thin film hydration</h3>
<p>To prepare polymersomes, PEG<sub>17</sub>-<em>b</em>-PPS<sub>30</sub>-Bz (10 mg) was measured and placed in a sterile 2 mL glass vial and dissolved in THF (200 μL). LatA (10 μg) was dissolved in THF (100 μL) and then combined with the polymer. The THF was removed <em>via</em> desiccation and the polymer deposit was rehydrated with PBS solution (1 mL, pH 7.4). The sample was shaken overnight at RT. Unencapsulated drug was removed by filtering samples with a Zeba spin desalting column (7 KD MWCO, 0.5 mL). Debris and nanoparticle aggregates were removed by filtering through a PTFE filter (0.2 μm, 14 mm).</p></section><section id="sec18"><h3 class="pmc_sec_title">Physiochemical properties</h3>
<p>Polymersome size and zeta potential were determined with dynamic light scattering (DLS, Zetasizer, Malvern, UK). Samples were prepared by diluting PS formulations (0.1–0.3 mg) in PBS (1 mL, pH 7.4) using a disposable low-volume sample cuvette. Particle morphology was visualized using cryogenic transmission electron microscopy (TEM, JEOL 1400 Flash,120 kV, JAPAN) and a Gatan OneView 4k camera. Nanostructure morphology was further confirmed by small angle X-ray scattering, which was performed at Argonne National Laboratories. Data reduction/buffer subtraction and model fitting were performed using the BioXTAS RAW 2.8.3 and SasView 5.0.5 software, respectively.<sup><a href="#cit57" class="usa-link" aria-describedby="cit57">57</a></sup> Vesicle sphere models were used to fit the data.</p></section><section id="sec19"><h3 class="pmc_sec_title">Quantification of LatA loading using HPLC</h3>
<p>To determine LatA drug loading, aliquots of LatA-loaded PS (0.1 mg) were dried under vacuum. The resulting solid was resuspended in 95% 100 μL methanol and sonicated for 5 min. The sample was placed at −80 °C for 6 h and centrifuged at 170 00<em>g</em> at 9 °C for 10 min. The supernatant was removed and the pellet was resuspended in 95% methanol and placed at −20 °C for 1 h. The solution was spun at 17 000<em>g</em> at −9 °C for 10 min. The supernatants from each spin were combined for analysis. The concentration of LatA was determined with RP-HPLC. HPLC was performed using a C18 column (Avantor) and methanol/water gradient for the mobile phase. Absorbance values were determined at 235 nm and LatA concentration was determined with a LatA calibration curve in methanol.</p></section><section id="sec20"><h3 class="pmc_sec_title">Labeling of aPD-1 with Flamma® Fluors 648</h3>
<p>Flamma® Fluors 648 was dissolved in DMSO (1 mg, 100 μL). APD-1 was dissolved in reaction buffer (500 mM carbonate, pH 9.5). The dye was slowly added to the aPD-1 solution and allowed to stir for 1 h at RT. The solution was dialyzed against water (20 KD MWCO, 12 mL) to remove any unconjugated dye.</p></section><section id="sec21"><h3 class="pmc_sec_title">Cytotoxicity in colon carcinoma cells and macrophages with MTT</h3>
<p>The cytotoxicity of free LatA and LatA-PS was evaluated using an MTT assay. Briefly, CT26 cells or RAW 264.7 macrophages were seeded on a 96-well plate (6 × 10<sup>4</sup> cells well<sup>−1</sup>) and allowed to adhere overnight. Cells were treated with complete media, free LatA (100 μL, 0.05, 0.5, 1, 2, 4 or 7 μM LatA) or LatA-PS (100 μL, 0.05, 0.5, 1, 2, 4 or 7 μM LatA) for 24 h. After incubation, the cells were washed and treated with MTT (100 μL, 0.4 mg mL<sup>−1</sup>) for 4 h. Then the media was removed and 150 μL DMSO was added to each well. Absorbance was detected at 630 nm (<em>A</em><sub>630</sub>) and 570 nm (<em>A</em><sub>570</sub>). Viability was calculated with the formula: viability (%) = (<em>A</em><sub>630</sub> − <em>A</em><sub>570</sub> of treated cells/<em>A</em><sub>630</sub> − <em>A</em><sub>570</sub> of untreated cells) × 100%.</p></section><section id="sec22"><h3 class="pmc_sec_title">Cytotoxicity in colon carcinoma cells and macrophages with flow cytometry</h3>
<p>The cytotoxicity of free LatA and LatA-PS was evaluated in RAW 264.7 macrophages by flow cytometry. RAW 264.7 macrophages were incubated with complete media, free LatA (100 μL, 0.01, 0.1, 1, or 10 μM) or LatA-PS (100 μL, 0.01, 0.1, 1, or 10 μM) for 24 h. Cells were collected and stained with Zombie NIR (1 μL in 1000 μL of cell staining buffer) for 15 min at RT. Flow cytometry was run (Aurora 3L, Cytek, USA) and the percentage of Zombie NIR-negative cells of singlets were determined with FlowJo<sup>TM</sup> software version 10.10. The percentage of Zombie-negative cells corresponded to cellular viability.</p></section><section id="sec23"><h3 class="pmc_sec_title">Kinetics of LatA-PS pinocytosis inhibition</h3>
<p>To determine when the effects of LatA-PS on pinocytosis start, DC2.4 cells were incubated cells with LatA-PS (2 μM) for 0.5 h and then with DiD-loaded polymersomes (DiD-PS) at the same polymer concentration for 6 h. To determine how long the effects of LatA-PS last, DC2.4 cells were incubated cells with LatA-PS (2 μM) for 2 h, allowed to recover for 0 h, 1 h or 2 h, and then incubated with DiD-PS for 6 h. Cellular uptake was measured <em>via</em> DiD fluorescence using flow cytometry. Data was analyzed using the FlowJo<sup>TM</sup> software version 10.10.</p></section><section id="sec24"><h3 class="pmc_sec_title">Effect of LatA on actin polymerization <em>in vitro</em> with confocal microscopy</h3>
<p>The effect of Lat A-PS on cells on actin polymerization was investigated with confocal microscopy. 3 × 10<sup>5</sup> RAW 264.7 cells were seeded on a 35 mm dish and incubated for 24 hours at 37 °C and 5.0% CO<sub>2</sub>. Cells were treated with Lat A-PS (7 μM) for 24 hours. Cells were fixed with 4% formaldehyde solution (15 min, RT). Then cells were washed and permeabilized with 0.5% Triton X-100 (15 min, RT). Cells were blocked with 3% bovine serum albumin (BSA) overnight prior to staining. To stain F-actin, cells were incubated with Alexa 488-Phalloidin diluted 1000× in 1% BSA (20 min, RT). Cells were washed with PBS and stained with NucBlue (1 drop mL<sup>−1</sup> media, 30 min, RT). Cells were washed again with fresh CDMEM and imaged with Nikon Super-resolution by Optical Re-assignment (SoRa) Spinning-disk Confocal System. Images were collected with a 60× oil immersion objective magnification lens was used with SoRa obtaining final magnification of 168×. The image was analyzed with NIS elements imaging software version 5.41.02.</p></section><section id="sec25"><h3 class="pmc_sec_title">Effect of LatA on aPD-1 engagement <em>in vitro</em>
</h3>
<p>The effect of LatA-PS on aPD-1 engagement with RAW 264.7 macrophages was investigated. Briefly, 8.1 × 10<sup>5</sup> cells were seeded on a 48-well plate and incubated for 24 h. Cells were then treated with either 7 μM LatA, 1 μM LatA or PBS for 24 h. Cells were washed and then incubated with Flamma® Fluors 648-labeled-aPD-1 (12.5 μg mL<sup>−1</sup>) for 2 h. Cells were washed to remove aPD-1 in solution and the fluorescence was (<em>λ</em><sub>ex</sub>: 646 nm <em>λ</em><sub>em</sub>: 648 nm) measured to approximate aPD-1 engagement with cells.</p></section><section id="sec26"><h3 class="pmc_sec_title">Uptake of aPD-1 <em>in vitro</em> with confocal microscopy</h3>
<p>RAW 264.7 macrophages were seeded on a 4-well confocal dish (2 × 10<sup>5</sup> cells well<sup>−1</sup>) and allowed to adhere overnight. Cells were treated with complete media, free LatA (500 μL, μM) or LatA-PS (500 μL, 2 μM) for 30 min. After incubation, the cells were washed and treated with Flamma® Fluors 648-labeled-aPD-1 (500 μL, 16 μM) for 15 min. Then the cells were washed and stained with NucBlue (1 drop mL<sup>−1</sup>) for 15 min. Confocal microscopy was performed (SP8, Leica, Germany) with a 63× oil immersion objective magnification lens.</p></section><section id="sec27"><h3 class="pmc_sec_title">aPD-1 organ-level biodistribution in cancer-bearing mice</h3>
<p>To establish murine melanoma, mice were injected subcutaneously with B16F10 cells (5 × 10<sup>5</sup>) in the right hind flank. Tumors were allowed to grow until ∼100 mm<sup>3</sup> at which point mice received a single 100 μg intravenous injection of Flamma® Fluors 648-labeled-aPD-1. Mice in LatA-PS or free LatA groups received two intravenous LatA doses (7 μM, 100 μL) 24 h and again 4 h prior to the aPD-1 injection. Tumor size was measured with calipers (<em>V</em> = 0.5<em>LW</em><sup>2</sup>, where <em>W</em> is the shorter perpendicular distance). aPD-1 tumor accumulation was measured with IVIS at 1 h, 12 h, 24 h, and 48 h after aPD-1 accumulation. Imaging angle was optimized to facilitate measuring tumor uptake in real time. Mice were sacrificed 48 h post-injection and <em>ex vivo</em> imaging of the heart, lung, spleen, liver, kidney and tumor was performed. Images were analyzed with the Living Image® software. For quantification, background elimination was performed by subtracting the average total radiant efficiency of untreated mice from each respective organ.</p></section><section id="sec28"><h3 class="pmc_sec_title">aPD-1 cellular-level biodistribution and immunophenotyping in cancer-bearing mice</h3>
<p>To establish colon carcinoma, mice were injected subcutaneously with CT26 cells (2 × 10<sup>5</sup>) in the right hind flank. Tumors were allowed to grow until ∼120 mm<sup>3</sup> at which point treatment with Flamma® Fluors 648-labeled-aPD-1 (10 mg kg<sup>−1</sup>) or a saline control was initiated. For all experiments, mice received 3 intraperitoneal aPD-1 injections, separated by 3 days. Mice in LatA-PS or free LatA groups received intravenous LatA injections (7 μM, 100 μL) 24 h and again 4 h prior to each aPD-1 injection. Tumor size was measured with calipers (<em>V</em> = 0.5<em>LW</em><sup>2</sup>, where <em>W</em> is the shorter perpendicular distance). One day after the final treatment the mice were sacrificed. The spleens and tumors were excised. Tumors were minced and digested with 600 μL of Collagenase III (3000 units mL<sup>−1</sup> in HBSS) or 400 μL of Liberase TH and 100 Kunitz units of DNase I. Then, single cell suspensions were generated by passing the digested tumor tissue and spleen through a 70 μm cell strainer. Red blood cells were removed with RBC lysis buffer (5 min, 4 °C). The harvested cells were stained with various antibodies to analyze with flow cytometry (Aurora 3L, Cytek, USA). Data analysis was performed FlowJo<sup>TM</sup> software version 10.10.</p></section><section id="sec29"><h3 class="pmc_sec_title">Tumor growth inhibition</h3>
<p>A CT26 model was established, and treatment was performed as described above, though unlabeled aPD-1. Body weight and tumor size were observed daily. Mice were sacrificed when tumors were 1000 mm<sup>3</sup> or at 40 days after treatment began, whichever came first. In some cases, the tumor and major organs were collected for further analysis.</p></section><section id="sec30"><h3 class="pmc_sec_title">Tumor spatial phenotyping</h3>
<p>Tumors were excised from mice at efficacy endpoints and embedded in OCT solution prior to freezing at −80 °C. Samples were sectioned, stained and imaged with a PhenoCycler-Fusion. Samples were analyzed using the QuPath software version 0.5.1. The DAPI signal of some Ki67 images were enhanced to normalize signal background.</p></section><section id="sec31"><h3 class="pmc_sec_title">Safety analysis</h3>
<p>The heart, lungs, liver, kidney and spleen from mice at efficacy endpoints were fixed in 10% neutral buffered formalin and embedded in paraffin prior to section. Hematoxylin and eosin staining was performed to evaluate organ-specific toxicity.</p></section><section id="sec32"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Statistics were performed using a one-way ANOVA and Tukey's multiple comparison test using the software GraphPad Prism version 10.4.1. Statistical significance was determined if the <em>p</em>-value was below 0.05. * <em>p</em>-value &lt; 0.05, ** <em>p</em>-value &lt; 0.01, *** <em>p</em>-value &lt; 0.001, **** <em>p</em>-value &lt; 0.001.</p></section></section><section id="sec33"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ADC</dt>
<dd><p>Antibody–drug–conjugate</p></dd>
<dt>aPD-1</dt>
<dd><p>Anti-programmed death receptor-1</p></dd>
<dt>FcR</dt>
<dd><p>Fc receptor</p></dd>
<dt>FcRn</dt>
<dd><p>Neonatal Fc receptor</p></dd>
<dt>ICI</dt>
<dd><p>Immune checkpoint inhibitor</p></dd>
<dt>IVIS</dt>
<dd><p>
<em>In vivo</em> imaging system</p></dd>
<dt>LatA</dt>
<dd><p>Latrunculin A</p></dd>
<dt>LatA-PS</dt>
<dd><p>LatA-loaded polymersome</p></dd>
<dt>MFI</dt>
<dd><p>Mean fluorescence intensity</p></dd>
<dt>MPS</dt>
<dd><p>Mononuclear phagocyte system</p></dd>
<dt>PEG-<em>b</em>-PPS-Bz</dt>
<dd><p>Poly(ethylene glycol)-<em>b</em>-poly(propylene sulfide)-benzyl</p></dd>
<dt>SAXS</dt>
<dd><p>Small angle X-ray scattering</p></dd>
<dt>RP-HPLC</dt>
<dd><p>Reverse-phase high performance liquid chromatography</p></dd>
<dt>TME</dt>
<dd><p>Tumor microenvironment</p></dd>
</dl></section><section id="sec34"><h2 class="pmc_sec_title">Author contributions</h2>
<p>S. R. Z. and H. P. designed the research with input from W. Q., G. L., E. S. and B. Z. S. R. Z. and H. P. performed experiments with the assistance of W. Q., G. L., S. A., S. H. S., D. B. S., J. L. and R. W. R. S. R. Z. and E. S. wrote and revised the manuscript. All authors have given approval to the final version of the manuscript.</p></section><section id="sec35"><h2 class="pmc_sec_title">Conflicts of interest</h2>
<p>There are no conflicts to declare.</p></section><section id="sec36"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="NH-010-D5NH00206K-s001"><div class="caption p"><span>NH-010-D5NH00206K-s001</span></div>
<div class="media p" id="d67e1356"><div class="caption">
<a href="/articles/instance/12186146/bin/NH-010-D5NH00206K-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">NH-010-D5NH00206K-s001.pdf</a><sup> (6.5MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This work was funded through NIH T32GM008449. CyroTEM was done by Eric Roth of the BioCryo Core. Confocal imaging was performed in the Biological Imaging Facility at Northwestern University (RRID:SCR_017767). Animal experiments were carried out with the assistance of the Developmental Therapeutics Core (RRID:SCR_017948). IVIS work was performed at the Northwestern University Center for Advanced Molecular Imaging (RRID:SCR_021192). Tumor tissue sectioning and PhenoCycler imaging were performed by the Immunotherapy Assessment Core. Histology was performed by the Mouse Histology &amp; Phenotyping Laboratory. Figures were made with BioRender.</p></section><section id="d67e145" class="bio"><h2 class="pmc_sec_title">Biography</h2>
<figure class="fig xbox font-sm" id="d67e148_fig39"><h3 class="obj_head">
Evan A. Scott
.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f04c/12186146/8fda46e8a296/d5nh00206k-p1.jpg" loading="lazy" id="plt1" height="787" width="630" alt="
Evan A. Scott
"></p>
<div class="p text-right font-secondary"><a href="figure/d67e148_fig39/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Nanoscale Horizons provides a critical and much needed outlet for new concepts in nanotechnology and was instrumental in the success of our research. Our first Nanoscale Horizons manuscript was a review article that we published back in 2019 to promote an underutilized yet highly promising nanostructure, the bicontinuous nanosphere. This spearheaded our work with this nanoparticle, leading to multiple subsequent publications and funded grant proposals. We again went to Nanoscale Horizons in 2021 to present our proof-of-concept data for our “indirect targeting” strategy, which we are honored to build upon here in our contribution to their well-earned 10th anniversary collection.</p></section><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<sup>†</sup><p class="display-inline">Electronic supplementary information (ESI) available: <sup>1</sup>H NMR spectrum and GPC data of synthesized polymer (Fig. S1); DLS, physiochemical properties and encapsulation efficiency of LatA-PS (Fig. S2) LatA viability on RAW 264.7 macrophages by flow cytometry (Fig. S3); <em>in vitro</em> uptake of DiD-PS after LatA-PS incubation in DC2.4 cells (Fig. S4); IVIS image of mice showing aPD-1 tumor uptake over 2 days (Fig. S5); representative flow cytometry plots of aPD-1 accumulation on a cellular level (Fig. S6); PhenoCycler images of myeloid cells in the TME with increased saturation (Fig. S7); PhenoCycler images of myeloid cells in the TME (Fig. S8); tumor images, Ki67 staining, body weight measurements and heart histology of mice (Fig. S9). See DOI: <a href="https://doi.org/10.1039/d5nh00206k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1039/d5nh00206k</a></p>
</div></div></section><section id="sec38"><h2 class="pmc_sec_title">Data availability</h2>
<p>The authors confirm that the data supporting the findings of this work is available within the article. The raw data is also accessible from the corresponding author upon reasonable request.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="cit1">
<cite>Mattiuzzi C. Lippi G. Current Cancer Epidemiology. J. Epidemiol. Glob. Health. 2019;9(4):217–222. doi: 10.2991/jegh.k.191008.001. <a href="https://doi.org/10.2991/jegh.k.191008.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.2991/jegh.k.191008.001</a></cite> [<a href="https://doi.org/10.2991/jegh.k.191008.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7310786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31854162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Epidemiol.%20Glob.%20Health&amp;title=Current%20Cancer%20Epidemiology&amp;author=C.%20Mattiuzzi&amp;author=G.%20Lippi&amp;volume=9&amp;issue=4&amp;publication_year=2019&amp;pages=217-222&amp;pmid=31854162&amp;doi=10.2991/jegh.k.191008.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit2">
<cite>Adams G. P. Weiner L. M. Monoclonal Antibody Therapy of Cancer. Nat. Biotechnol. 2005;23(9):1147–1157. doi: 10.1038/nbt1137. <a href="https://doi.org/10.1038/nbt1137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/nbt1137</a></cite> [<a href="https://doi.org/10.1038/nbt1137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16151408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Monoclonal%20Antibody%20Therapy%20of%20Cancer&amp;author=G.%20P.%20Adams&amp;author=L.%20M.%20Weiner&amp;volume=23&amp;issue=9&amp;publication_year=2005&amp;pages=1147-1157&amp;pmid=16151408&amp;doi=10.1038/nbt1137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit3">
<cite>Cruz E. Kayser V. Monoclonal Antibody Therapy of Solid Tumors: Clinical Limitations and Novel Strategies to Enhance Treatment Efficacy. Biol.: Targets Ther. 2019;13:33–51. doi: 10.2147/BTT.S166310.</cite> [<a href="https://doi.org/10.2147/BTT.S166310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6503308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31118560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol.:%20Targets%20Ther.&amp;title=Monoclonal%20Antibody%20Therapy%20of%20Solid%20Tumors:%20Clinical%20Limitations%20and%20Novel%20Strategies%20to%20Enhance%20Treatment%20Efficacy&amp;author=E.%20Cruz&amp;author=V.%20Kayser&amp;volume=13&amp;publication_year=2019&amp;pages=33-51&amp;pmid=31118560&amp;doi=10.2147/BTT.S166310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit4">
<cite>Kontermann R. E. Strategies to Extend Plasma Half-Lives of Recombinant Antibodies. BioDrugs. 2009;23(2):93–109. doi: 10.2165/00063030-200923020-00003. <a href="https://doi.org/10.2165/00063030-200923020-00003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.2165/00063030-200923020-00003</a></cite> [<a href="https://doi.org/10.2165/00063030-200923020-00003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19489651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioDrugs&amp;title=Strategies%20to%20Extend%20Plasma%20Half-Lives%20of%20Recombinant%20Antibodies&amp;author=R.%20E.%20Kontermann&amp;volume=23&amp;issue=2&amp;publication_year=2009&amp;pages=93-109&amp;pmid=19489651&amp;doi=10.2165/00063030-200923020-00003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit5">
<cite>Shah A. Rauth S. Aithal A. Kaur S. Ganguly K. Orzechowski C. Varshney G. C. Jain M. Batra S. K. The Current Landscape of Antibody-Based Therapies in Solid Malignancies. Theranostics. 2021;11(3):1493–1512. doi: 10.7150/thno.52614. <a href="https://doi.org/10.7150/thno.52614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.7150/thno.52614</a></cite> [<a href="https://doi.org/10.7150/thno.52614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7738893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33391547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=The%20Current%20Landscape%20of%20Antibody-Based%20Therapies%20in%20Solid%20Malignancies&amp;author=A.%20Shah&amp;author=S.%20Rauth&amp;author=A.%20Aithal&amp;author=S.%20Kaur&amp;author=K.%20Ganguly&amp;volume=11&amp;issue=3&amp;publication_year=2021&amp;pages=1493-1512&amp;pmid=33391547&amp;doi=10.7150/thno.52614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit6">
<cite>Ovacik M. Lin K. Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development. Clin. Transl. Sci. 2018;11(6):540–552. doi: 10.1111/cts.12567. <a href="https://doi.org/10.1111/cts.12567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1111/cts.12567</a></cite> [<a href="https://doi.org/10.1111/cts.12567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6226118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29877608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Transl.%20Sci.&amp;title=Tutorial%20on%20Monoclonal%20Antibody%20Pharmacokinetics%20and%20Its%20Considerations%20in%20Early%20Development&amp;author=M.%20Ovacik&amp;author=K.%20Lin&amp;volume=11&amp;issue=6&amp;publication_year=2018&amp;pages=540-552&amp;pmid=29877608&amp;doi=10.1111/cts.12567&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit7">
<cite>Kamath A. V. Translational Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies. Drug Discovery Today Technol. 2016;21–22:75–83. doi: 10.1016/j.ddtec.2016.09.004. <a href="https://doi.org/10.1016/j.ddtec.2016.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.ddtec.2016.09.004</a></cite> [<a href="https://doi.org/10.1016/j.ddtec.2016.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27978991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discovery%20Today%20Technol.&amp;title=Translational%20Pharmacokinetics%20and%20Pharmacodynamics%20of%20Monoclonal%20Antibodies&amp;author=A.%20V.%20Kamath&amp;volume=21%E2%80%9322&amp;publication_year=2016&amp;pages=75-83&amp;pmid=27978991&amp;doi=10.1016/j.ddtec.2016.09.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit8">
<cite>Bordeau B. M. Balthasar J. P. Strategies to Enhance Monoclonal Antibody Uptake and Distribution in Solid Tumors. Cancer Biol. Med. 2021;18(3):649–664. doi: 10.20892/j.issn.2095-3941.2020.0704.</cite> [<a href="https://doi.org/10.20892/j.issn.2095-3941.2020.0704" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8330533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35979855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol.%20Med.&amp;title=Strategies%20to%20Enhance%20Monoclonal%20Antibody%20Uptake%20and%20Distribution%20in%20Solid%20Tumors&amp;author=B.%20M.%20Bordeau&amp;author=J.%20P.%20Balthasar&amp;volume=18&amp;issue=3&amp;publication_year=2021&amp;pages=649-664&amp;pmid=35979855&amp;doi=10.20892/j.issn.2095-3941.2020.0704&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit9">
<cite>Kurino T. Matsuda R. Terui A. Suzuki H. Kokubo T. Uehara T. Arano Y. Hisaka A. Hatakeyama H. Poor Outcome with Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models. J. Immunother. Cancer. 2020;8(1):e000400. doi: 10.1136/jitc-2019-000400. <a href="https://doi.org/10.1136/jitc-2019-000400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1136/jitc-2019-000400</a></cite> [<a href="https://doi.org/10.1136/jitc-2019-000400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7057431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32041818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Immunother.%20Cancer&amp;title=Poor%20Outcome%20with%20Anti-Programmed%20Death-Ligand%201%20(PD-L1)%20Antibody%20Due%20to%20Poor%20Pharmacokinetic%20Properties%20in%20PD-1/PD-L1%20Blockade-Sensitive%20Mouse%20Models&amp;author=T.%20Kurino&amp;author=R.%20Matsuda&amp;author=A.%20Terui&amp;author=H.%20Suzuki&amp;author=T.%20Kokubo&amp;volume=8&amp;issue=1&amp;publication_year=2020&amp;pages=e000400&amp;pmid=32041818&amp;doi=10.1136/jitc-2019-000400&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit10">
<cite>Chow A. Brown B. D. Merad M. Studying the Mononuclear Phagocyte System in the Molecular Age. Nat. Rev. Immunol. 2011;11(11):788–798. doi: 10.1038/nri3087. <a href="https://doi.org/10.1038/nri3087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/nri3087</a></cite> [<a href="https://doi.org/10.1038/nri3087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22025056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Immunol.&amp;title=Studying%20the%20Mononuclear%20Phagocyte%20System%20in%20the%20Molecular%20Age&amp;author=A.%20Chow&amp;author=B.%20D.%20Brown&amp;author=M.%20Merad&amp;volume=11&amp;issue=11&amp;publication_year=2011&amp;pages=788-798&amp;pmid=22025056&amp;doi=10.1038/nri3087&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit11">
<cite>Halma C. Daha M. R. Van Es L. A. 
In Vivo Clearance by the Mononuclear Phagocyte System in Humans: An Overview of Methods and Their Interpretation. Clin. Exp. Immunol. 2008;89(1):1–7. doi: 10.1111/j.1365-2249.1992.tb06868.x. <a href="https://doi.org/10.1111/j.1365-2249.1992.tb06868.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1111/j.1365-2249.1992.tb06868.x</a></cite> [<a href="https://doi.org/10.1111/j.1365-2249.1992.tb06868.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1554409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1628416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Exp.%20Immunol.&amp;title=In%20Vivo%20Clearance%20by%20the%20Mononuclear%20Phagocyte%20System%20in%20Humans:%20An%20Overview%20of%20Methods%20and%20Their%20Interpretation&amp;author=C.%20Halma&amp;author=M.%20R.%20Daha&amp;author=L.%20A.%20Van%20Es&amp;volume=89&amp;issue=1&amp;publication_year=2008&amp;pages=1-7&amp;pmid=1628416&amp;doi=10.1111/j.1365-2249.1992.tb06868.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit12">
<cite>Gustafson H. H. Holt-Casper D. Grainger D. W. Ghandehari H. Nanoparticle Uptake: The Phagocyte Problem. Nano Today. 2015;10(4):487–510. doi: 10.1016/j.nantod.2015.06.006. <a href="https://doi.org/10.1016/j.nantod.2015.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.nantod.2015.06.006</a></cite> [<a href="https://doi.org/10.1016/j.nantod.2015.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4666556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26640510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Today&amp;title=Nanoparticle%20Uptake:%20The%20Phagocyte%20Problem&amp;author=H.%20H.%20Gustafson&amp;author=D.%20Holt-Casper&amp;author=D.%20W.%20Grainger&amp;author=H.%20Ghandehari&amp;volume=10&amp;issue=4&amp;publication_year=2015&amp;pages=487-510&amp;pmid=26640510&amp;doi=10.1016/j.nantod.2015.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit13">
<cite>Nguyen T. D. Bordeau B. M. Balthasar J. P. Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability. Cancers. 2023;15(3):713. doi: 10.3390/cancers15030713. <a href="https://doi.org/10.3390/cancers15030713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.3390/cancers15030713</a></cite> [<a href="https://doi.org/10.3390/cancers15030713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9913659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36765668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Mechanisms%20of%20ADC%20Toxicity%20and%20Strategies%20to%20Increase%20ADC%20Tolerability&amp;author=T.%20D.%20Nguyen&amp;author=B.%20M.%20Bordeau&amp;author=J.%20P.%20Balthasar&amp;volume=15&amp;issue=3&amp;publication_year=2023&amp;pages=713&amp;pmid=36765668&amp;doi=10.3390/cancers15030713&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit14">
<cite>Igawa T. Tsunoda H. Tachibana T. Maeda A. Mimoto F. Moriyama C. Nanami M. Sekimori Y. Nabuchi Y. Aso Y. Hattori K. Reduced Elimination of IgG Antibodies by Engineering the Variable Region. Protein Eng., Des. Sel. 2010;23(5):385–392. doi: 10.1093/protein/gzq009. <a href="https://doi.org/10.1093/protein/gzq009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1093/protein/gzq009</a></cite> [<a href="https://doi.org/10.1093/protein/gzq009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20159773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Protein%20Eng.,%20Des.%20Sel.&amp;title=Reduced%20Elimination%20of%20IgG%20Antibodies%20by%20Engineering%20the%20Variable%20Region&amp;author=T.%20Igawa&amp;author=H.%20Tsunoda&amp;author=T.%20Tachibana&amp;author=A.%20Maeda&amp;author=F.%20Mimoto&amp;volume=23&amp;issue=5&amp;publication_year=2010&amp;pages=385-392&amp;pmid=20159773&amp;doi=10.1093/protein/gzq009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit15">
<cite>Carter P. J. Quarmby V. Immunogenicity Risk Assessment and Mitigation for Engineered Antibody and Protein Therapeutics. Nat. Rev. Drug Discovery. 2024;23(12):898–913. doi: 10.1038/s41573-024-01051-x. <a href="https://doi.org/10.1038/s41573-024-01051-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/s41573-024-01051-x</a></cite> [<a href="https://doi.org/10.1038/s41573-024-01051-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39424922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discovery&amp;title=Immunogenicity%20Risk%20Assessment%20and%20Mitigation%20for%20Engineered%20Antibody%20and%20Protein%20Therapeutics&amp;author=P.%20J.%20Carter&amp;author=V.%20Quarmby&amp;volume=23&amp;issue=12&amp;publication_year=2024&amp;pages=898-913&amp;pmid=39424922&amp;doi=10.1038/s41573-024-01051-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit16">
<cite>Sheridan C. Pancreatic Cancer Provides Testbed for First Mechanotherapeutics. Nat. Biotechnol. 2019;37(8):829–831. doi: 10.1038/d41587-019-00019-2. <a href="https://doi.org/10.1038/d41587-019-00019-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/d41587-019-00019-2</a></cite> [<a href="https://doi.org/10.1038/d41587-019-00019-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31375797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Pancreatic%20Cancer%20Provides%20Testbed%20for%20First%20Mechanotherapeutics&amp;author=C.%20Sheridan&amp;volume=37&amp;issue=8&amp;publication_year=2019&amp;pages=829-831&amp;pmid=31375797&amp;doi=10.1038/d41587-019-00019-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit17">
<cite>Zalevsky J. Chamberlain A. K. Horton H. M. Karki S. Leung I. W. L. Sproule T. J. Lazar G. A. Roopenian D. C. Desjarlais J. R. Enhanced Antibody Half-Life Improves in Vivo Activity. Nat. Biotechnol. 2010;28(2):157–159. doi: 10.1038/nbt.1601. <a href="https://doi.org/10.1038/nbt.1601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/nbt.1601</a></cite> [<a href="https://doi.org/10.1038/nbt.1601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2855492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20081867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Enhanced%20Antibody%20Half-Life%20Improves%20in%20Vivo%20Activity&amp;author=J.%20Zalevsky&amp;author=A.%20K.%20Chamberlain&amp;author=H.%20M.%20Horton&amp;author=S.%20Karki&amp;author=I.%20W.%20L.%20Leung&amp;volume=28&amp;issue=2&amp;publication_year=2010&amp;pages=157-159&amp;pmid=20081867&amp;doi=10.1038/nbt.1601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit18">
<cite>Stack T. Liu Y. Frey M. Bobbala S. Vincent M. Scott E. Enhancing Subcutaneous Injection and Target Tissue Accumulation of Nanoparticles via Co-Administration with Macropinocytosis Inhibitory Nanoparticles (MiNP) Nanoscale Horiz. 2021;6(5):393–400. doi: 10.1039/D0NH00679C. <a href="https://doi.org/10.1039/D0NH00679C" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1039/D0NH00679C</a></cite> [<a href="https://doi.org/10.1039/D0NH00679C" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8127988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33884386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale%20Horiz.&amp;title=Enhancing%20Subcutaneous%20Injection%20and%20Target%20Tissue%20Accumulation%20of%20Nanoparticles%20via%20Co-Administration%20with%20Macropinocytosis%20Inhibitory%20Nanoparticles%20(MiNP)&amp;author=T.%20Stack&amp;author=Y.%20Liu&amp;author=M.%20Frey&amp;author=S.%20Bobbala&amp;author=M.%20Vincent&amp;volume=6&amp;issue=5&amp;publication_year=2021&amp;pages=393-400&amp;pmid=33884386&amp;doi=10.1039/D0NH00679C&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit19">
<cite>Vincent M. P. Navidzadeh J. O. Bobbala S. Scott E. A. Leveraging Self-Assembled Nanobiomaterials for Improved Cancer Immunotherapy. Cancer Cell. 2022;40(3):255–276. doi: 10.1016/j.ccell.2022.01.006. <a href="https://doi.org/10.1016/j.ccell.2022.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.ccell.2022.01.006</a></cite> [<a href="https://doi.org/10.1016/j.ccell.2022.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8930620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35148814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Leveraging%20Self-Assembled%20Nanobiomaterials%20for%20Improved%20Cancer%20Immunotherapy&amp;author=M.%20P.%20Vincent&amp;author=J.%20O.%20Navidzadeh&amp;author=S.%20Bobbala&amp;author=E.%20A.%20Scott&amp;volume=40&amp;issue=3&amp;publication_year=2022&amp;pages=255-276&amp;pmid=35148814&amp;doi=10.1016/j.ccell.2022.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit20">
<cite>Munari E. Mariotti F. R. Quatrini L. Bertoglio P. Tumino N. Vacca P. Eccher A. Ciompi F. Brunelli M. Martignoni G. Bogina G. Moretta L. PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects. Int. J. Mol. Sci. 2021;22(10):5123. doi: 10.3390/ijms22105123. <a href="https://doi.org/10.3390/ijms22105123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.3390/ijms22105123</a></cite> [<a href="https://doi.org/10.3390/ijms22105123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8151504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34066087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=PD-1/PD-L1%20in%20Cancer:%20Pathophysiological,%20Diagnostic%20and%20Therapeutic%20Aspects&amp;author=E.%20Munari&amp;author=F.%20R.%20Mariotti&amp;author=L.%20Quatrini&amp;author=P.%20Bertoglio&amp;author=N.%20Tumino&amp;volume=22&amp;issue=10&amp;publication_year=2021&amp;pages=5123&amp;pmid=34066087&amp;doi=10.3390/ijms22105123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit21">
<cite>Zhong W. Myers J. S. Wang F. Wang K. Lucas J. Rosfjord E. Lucas J. Hooper A. T. Yang S. Lemon L. A. Guffroy M. May C. Bienkowska J. R. Rejto P. A. Comparison of the Molecular and Cellular Phenotypes of Common Mouse Syngeneic Models with Human Tumors. BMC Genomics. 2020;21(1):2. doi: 10.1186/s12864-019-6344-3. <a href="https://doi.org/10.1186/s12864-019-6344-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1186/s12864-019-6344-3</a></cite> [<a href="https://doi.org/10.1186/s12864-019-6344-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6941261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31898484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=Comparison%20of%20the%20Molecular%20and%20Cellular%20Phenotypes%20of%20Common%20Mouse%20Syngeneic%20Models%20with%20Human%20Tumors&amp;author=W.%20Zhong&amp;author=J.%20S.%20Myers&amp;author=F.%20Wang&amp;author=K.%20Wang&amp;author=J.%20Lucas&amp;volume=21&amp;issue=1&amp;publication_year=2020&amp;pages=2&amp;pmid=31898484&amp;doi=10.1186/s12864-019-6344-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit22">
<cite>Stack T. Vincent M. Vahabikashi A. Li G. Perkumas K. M. Stamer W. D. Johnson M. Scott E. Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma. Small. 2020;16(43):2004205. doi: 10.1002/smll.202004205. <a href="https://doi.org/10.1002/smll.202004205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1002/smll.202004205</a></cite> [<a href="https://doi.org/10.1002/smll.202004205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7647937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33015961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&amp;title=Targeted%20Delivery%20of%20Cell%20Softening%20Micelles%20to%20Schlemm's%20Canal%20Endothelial%20Cells%20for%20Treatment%20of%20Glaucoma&amp;author=T.%20Stack&amp;author=M.%20Vincent&amp;author=A.%20Vahabikashi&amp;author=G.%20Li&amp;author=K.%20M.%20Perkumas&amp;volume=16&amp;issue=43&amp;publication_year=2020&amp;pages=2004205&amp;pmid=33015961&amp;doi=10.1002/smll.202004205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit23">
<cite>Burke J. A. Zhang X. Bobbala S. Frey M. A. Bohorquez Fuentes C. Freire Haddad H. Allen S. D. Richardson R. A. K. Ameer G. A. Scott E. A. Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability. Nat. Nanotechnol. 2022;17(3):319–330. doi: 10.1038/s41565-021-01048-2. <a href="https://doi.org/10.1038/s41565-021-01048-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/s41565-021-01048-2</a></cite> [<a href="https://doi.org/10.1038/s41565-021-01048-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8934301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35039683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Nanotechnol.&amp;title=Subcutaneous%20Nanotherapy%20Repurposes%20the%20Immunosuppressive%20Mechanism%20of%20Rapamycin%20to%20Enhance%20Allogeneic%20Islet%20Graft%20Viability&amp;author=J.%20A.%20Burke&amp;author=X.%20Zhang&amp;author=S.%20Bobbala&amp;author=M.%20A.%20Frey&amp;author=C.%20Bohorquez%20Fuentes&amp;volume=17&amp;issue=3&amp;publication_year=2022&amp;pages=319-330&amp;pmid=35039683&amp;doi=10.1038/s41565-021-01048-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit24">
<cite>Nel A. E. Mädler L. Velegol D. Xia T. Hoek E. M. V. Somasundaran P. Klaessig F. Castranova V. Thompson M. Understanding Biophysicochemical Interactions at the Nano–Bio Interface. Nat. Mater. 2009;8(7):543–557. doi: 10.1038/nmat2442. <a href="https://doi.org/10.1038/nmat2442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/nmat2442</a></cite> [<a href="https://doi.org/10.1038/nmat2442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19525947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Mater.&amp;title=Understanding%20Biophysicochemical%20Interactions%20at%20the%20Nano%E2%80%93Bio%20Interface&amp;author=A.%20E.%20Nel&amp;author=L.%20M%C3%A4dler&amp;author=D.%20Velegol&amp;author=T.%20Xia&amp;author=E.%20M.%20V.%20Hoek&amp;volume=8&amp;issue=7&amp;publication_year=2009&amp;pages=543-557&amp;pmid=19525947&amp;doi=10.1038/nmat2442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit25">
<cite>Zelepukin I. V. Shevchenko K. G. Deyev S. M. Rediscovery of Mononuclear Phagocyte System Blockade for Nanoparticle Drug Delivery. Nat. Commun. 2024;15(1):4366. doi: 10.1038/s41467-024-48838-5. <a href="https://doi.org/10.1038/s41467-024-48838-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/s41467-024-48838-5</a></cite> [<a href="https://doi.org/10.1038/s41467-024-48838-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11111695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38777821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Rediscovery%20of%20Mononuclear%20Phagocyte%20System%20Blockade%20for%20Nanoparticle%20Drug%20Delivery&amp;author=I.%20V.%20Zelepukin&amp;author=K.%20G.%20Shevchenko&amp;author=S.%20M.%20Deyev&amp;volume=15&amp;issue=1&amp;publication_year=2024&amp;pages=4366&amp;pmid=38777821&amp;doi=10.1038/s41467-024-48838-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit26">
<cite>Scott E. A. Stano A. Gillard M. Maio-Liu A. C. Swartz M. A. Hubbell J. A. Dendritic Cell Activation and T Cell Priming with Adjuvant- and Antigen-Loaded Oxidation-Sensitive Polymersomes. Biomaterials. 2012;33(26):6211–6219. doi: 10.1016/j.biomaterials.2012.04.060. <a href="https://doi.org/10.1016/j.biomaterials.2012.04.060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.biomaterials.2012.04.060</a></cite> [<a href="https://doi.org/10.1016/j.biomaterials.2012.04.060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22658634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Dendritic%20Cell%20Activation%20and%20T%20Cell%20Priming%20with%20Adjuvant-%20and%20Antigen-Loaded%20Oxidation-Sensitive%20Polymersomes&amp;author=E.%20A.%20Scott&amp;author=A.%20Stano&amp;author=M.%20Gillard&amp;author=A.%20C.%20Maio-Liu&amp;author=M.%20A.%20Swartz&amp;volume=33&amp;issue=26&amp;publication_year=2012&amp;pages=6211-6219&amp;pmid=22658634&amp;doi=10.1016/j.biomaterials.2012.04.060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit27">
<cite>Yi S. Allen S. D. Liu Y.-G. Ouyang B. Z. Li X. Augsornworawat P. Thorp E. B. Scott E. A. Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis. ACS Nano. 2016;10(12):11290–11303. doi: 10.1021/acsnano.6b06451. <a href="https://doi.org/10.1021/acsnano.6b06451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1021/acsnano.6b06451</a></cite> [<a href="https://doi.org/10.1021/acsnano.6b06451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5418862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27935698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Tailoring%20Nanostructure%20Morphology%20for%20Enhanced%20Targeting%20of%20Dendritic%20Cells%20in%20Atherosclerosis&amp;author=S.%20Yi&amp;author=S.%20D.%20Allen&amp;author=Y.-G.%20Liu&amp;author=B.%20Z.%20Ouyang&amp;author=X.%20Li&amp;volume=10&amp;issue=12&amp;publication_year=2016&amp;pages=11290-11303&amp;pmid=27935698&amp;doi=10.1021/acsnano.6b06451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit28">
<cite>Remash D. Prince D. S. McKenzie C. Strasser S. I. Kao S. Liu K. Immune Checkpoint Inhibitor-Related Hepatotoxicity: A Review. World J. Gastroenterol. 2021;27(32):5376–5391. doi: 10.3748/wjg.v27.i32.5376. <a href="https://doi.org/10.3748/wjg.v27.i32.5376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.3748/wjg.v27.i32.5376</a></cite> [<a href="https://doi.org/10.3748/wjg.v27.i32.5376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8409159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34539139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J.%20Gastroenterol.&amp;title=Immune%20Checkpoint%20Inhibitor-Related%20Hepatotoxicity:%20A%20Review&amp;author=D.%20Remash&amp;author=D.%20S.%20Prince&amp;author=C.%20McKenzie&amp;author=S.%20I.%20Strasser&amp;author=S.%20Kao&amp;volume=27&amp;issue=32&amp;publication_year=2021&amp;pages=5376-5391&amp;pmid=34539139&amp;doi=10.3748/wjg.v27.i32.5376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit29">
<cite>Adam K. Iuga A. Tocheva A. S. Mor A. A Novel Mouse Model for Checkpoint Inhibitor-Induced Adverse Events. PLoS One. 2021;16(2):e0246168. doi: 10.1371/journal.pone.0246168. <a href="https://doi.org/10.1371/journal.pone.0246168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1371/journal.pone.0246168</a></cite> [<a href="https://doi.org/10.1371/journal.pone.0246168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7877613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33571254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=A%20Novel%20Mouse%20Model%20for%20Checkpoint%20Inhibitor-Induced%20Adverse%20Events&amp;author=K.%20Adam&amp;author=A.%20Iuga&amp;author=A.%20S.%20Tocheva&amp;author=A.%20Mor&amp;volume=16&amp;issue=2&amp;publication_year=2021&amp;pages=e0246168&amp;pmid=33571254&amp;doi=10.1371/journal.pone.0246168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit30">
<cite>Konishi H. Kikuchi S. Ochiai T. Ikoma H. Kubota T. Ichikawa D. Fujiwara H. Okamoto K. Sakakura C. Sonoyama T. Kokuba Y. Sasaki H. Matsui T. Otsuji E. Latrunculin a Has a Strong Anticancer Effect in a Peritoneal Dissemination Model of Human Gastric Cancer in Mice. Anticancer Res. 2009;29(6):2091–2097.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/19528469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res.&amp;title=Latrunculin%20a%20Has%20a%20Strong%20Anticancer%20Effect%20in%20a%20Peritoneal%20Dissemination%20Model%20of%20Human%20Gastric%20Cancer%20in%20Mice&amp;author=H.%20Konishi&amp;author=S.%20Kikuchi&amp;author=T.%20Ochiai&amp;author=H.%20Ikoma&amp;author=T.%20Kubota&amp;volume=29&amp;issue=6&amp;publication_year=2009&amp;pages=2091-2097&amp;pmid=19528469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit31">
<cite>Latrunculins—Novel Marine Macrolides That Disrupt Microfilament Organization and Affect Cell Growth: I. Comparison with Cytochalasin D</cite> [<a href="https://doi.org/10.1002/cm.970130302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2776221/" class="usa-link">PubMed</a>]</li>
<li id="cit32">
<cite>Stack T. Vahabikashi A. Johnson M. Scott E. Modulation of Schlemm's Canal Endothelial Cell Stiffness via Latrunculin Loaded Block Copolymer Micelles. J. Biomed. Mater. Res., Part A. 2018;106(7):1771–1779. doi: 10.1002/jbm.a.36376. <a href="https://doi.org/10.1002/jbm.a.36376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1002/jbm.a.36376</a></cite> [<a href="https://doi.org/10.1002/jbm.a.36376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5980717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29468812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomed.%20Mater.%20Res.,%20Part%20A&amp;title=Modulation%20of%20Schlemm's%20Canal%20Endothelial%20Cell%20Stiffness%20via%20Latrunculin%20Loaded%20Block%20Copolymer%20Micelles&amp;author=T.%20Stack&amp;author=A.%20Vahabikashi&amp;author=M.%20Johnson&amp;author=E.%20Scott&amp;volume=106&amp;issue=7&amp;publication_year=2018&amp;pages=1771-1779&amp;pmid=29468812&amp;doi=10.1002/jbm.a.36376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit33">
<cite>Geraud A. Gougis P. Vozy A. Anquetil C. Allenbach Y. Romano E. Funck-Brentano E. Moslehi J. J. Johnson D. B. Salem J.-E. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance. Annu. Rev. Pharmacol. Toxicol. 2021;61(1):85–112. doi: 10.1146/annurev-pharmtox-022820-093805. <a href="https://doi.org/10.1146/annurev-pharmtox-022820-093805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1146/annurev-pharmtox-022820-093805</a></cite> [<a href="https://doi.org/10.1146/annurev-pharmtox-022820-093805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32871087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Pharmacol.%20Toxicol.&amp;title=Clinical%20Pharmacology%20and%20Interplay%20of%20Immune%20Checkpoint%20Agents:%20A%20Yin-Yang%20Balance&amp;author=A.%20Geraud&amp;author=P.%20Gougis&amp;author=A.%20Vozy&amp;author=C.%20Anquetil&amp;author=Y.%20Allenbach&amp;volume=61&amp;issue=1&amp;publication_year=2021&amp;pages=85-112&amp;pmid=32871087&amp;doi=10.1146/annurev-pharmtox-022820-093805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit34">
<cite>Lechner M. G. Karimi S. S. Barry-Holson K. Angell T. E. Murphy K. A. Church C. H. Ohlfest J. R. Hu P. Epstein A. L. Immunogenicity of Murine Solid Tumor Models as a Defining Feature of in Vivo Behavior and Response to Immunotherapy. J. Immunother. 2013;36(9):477–489. doi: 10.1097/01.cji.0000436722.46675.4a. <a href="https://doi.org/10.1097/01.cji.0000436722.46675.4a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1097/01.cji.0000436722.46675.4a</a></cite> [<a href="https://doi.org/10.1097/01.cji.0000436722.46675.4a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3910494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24145359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Immunother.&amp;title=Immunogenicity%20of%20Murine%20Solid%20Tumor%20Models%20as%20a%20Defining%20Feature%20of%20in%20Vivo%20Behavior%20and%20Response%20to%20Immunotherapy&amp;author=M.%20G.%20Lechner&amp;author=S.%20S.%20Karimi&amp;author=K.%20Barry-Holson&amp;author=T.%20E.%20Angell&amp;author=K.%20A.%20Murphy&amp;volume=36&amp;issue=9&amp;publication_year=2013&amp;pages=477-489&amp;pmid=24145359&amp;doi=10.1097/01.cji.0000436722.46675.4a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit35">
<cite>Lobo C. S. Mendes M. I. P. Pereira D. A. Gomes-da-Silva L. C. Arnaut L. G. Photodynamic Therapy Changes Tumour Immunogenicity and Promotes Immune-Checkpoint Blockade Response, Particularly When Combined with Micromechanical Priming. Sci. Rep. 2023;13(1):11667. doi: 10.1038/s41598-023-38862-8. <a href="https://doi.org/10.1038/s41598-023-38862-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/s41598-023-38862-8</a></cite> [<a href="https://doi.org/10.1038/s41598-023-38862-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10356828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37468749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Photodynamic%20Therapy%20Changes%20Tumour%20Immunogenicity%20and%20Promotes%20Immune-Checkpoint%20Blockade%20Response,%20Particularly%20When%20Combined%20with%20Micromechanical%20Priming&amp;author=C.%20S.%20Lobo&amp;author=M.%20I.%20P.%20Mendes&amp;author=D.%20A.%20Pereira&amp;author=L.%20C.%20Gomes-da-Silva&amp;author=L.%20G.%20Arnaut&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=11667&amp;pmid=37468749&amp;doi=10.1038/s41598-023-38862-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit36">
<cite>Davodabadi F. Sajjadi S. F. Sarhadi M. Mirghasemi S. Nadali Hezaveh M. Khosravi S. Kamali Andani M. Cordani M. Basiri M. Ghavami S. Cancer Chemotherapy Resistance: Mechanisms and Recent Breakthrough in Targeted Drug Delivery. Eur. J. Pharmacol. 2023;958:176013. doi: 10.1016/j.ejphar.2023.176013. <a href="https://doi.org/10.1016/j.ejphar.2023.176013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.ejphar.2023.176013</a></cite> [<a href="https://doi.org/10.1016/j.ejphar.2023.176013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37633322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharmacol.&amp;title=Cancer%20Chemotherapy%20Resistance:%20Mechanisms%20and%20Recent%20Breakthrough%20in%20Targeted%20Drug%20Delivery&amp;author=F.%20Davodabadi&amp;author=S.%20F.%20Sajjadi&amp;author=M.%20Sarhadi&amp;author=S.%20Mirghasemi&amp;author=M.%20Nadali%20Hezaveh&amp;volume=958&amp;publication_year=2023&amp;pages=176013&amp;pmid=37633322&amp;doi=10.1016/j.ejphar.2023.176013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit37">
<cite>Simon S. Labarriere N. PD-1 Expression on Tumor-Specific T Cells: Friend or Foe for Immunotherapy? OncoImmunology. 2018;7(1):e1364828. doi: 10.1080/2162402X.2017.1364828. <a href="https://doi.org/10.1080/2162402X.2017.1364828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1080/2162402X.2017.1364828</a></cite> [<a href="https://doi.org/10.1080/2162402X.2017.1364828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5739549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29296515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=OncoImmunology&amp;title=PD-1%20Expression%20on%20Tumor-Specific%20T%20Cells:%20Friend%20or%20Foe%20for%20Immunotherapy?&amp;author=S.%20Simon&amp;author=N.%20Labarriere&amp;volume=7&amp;issue=1&amp;publication_year=2018&amp;pages=e1364828&amp;pmid=29296515&amp;doi=10.1080/2162402X.2017.1364828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit38">
<cite>Lee J. Ahn E. Kissick H. T. Ahmed R. Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway. Forum Immunopathol. Dis. Ther. 2015;6(1–2):7–17. doi: 10.1615/ForumImmunDisTher.2015014188. <a href="https://doi.org/10.1615/ForumImmunDisTher.2015014188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1615/ForumImmunDisTher.2015014188</a></cite> [<a href="https://doi.org/10.1615/ForumImmunDisTher.2015014188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5341794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28286692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Forum%20Immunopathol.%20Dis.%20Ther.&amp;title=Reinvigorating%20Exhausted%20T%20Cells%20by%20Blockade%20of%20the%20PD-1%20Pathway&amp;author=J.%20Lee&amp;author=E.%20Ahn&amp;author=H.%20T.%20Kissick&amp;author=R.%20Ahmed&amp;volume=6&amp;issue=1%E2%80%932&amp;publication_year=2015&amp;pages=7-17&amp;pmid=28286692&amp;doi=10.1615/ForumImmunDisTher.2015014188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit39">
<cite>Irvine D. J. Hanson M. C. Rakhra K. Tokatlian T. Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem. Rev. 2015;115(19):11109–11146. doi: 10.1021/acs.chemrev.5b00109. <a href="https://doi.org/10.1021/acs.chemrev.5b00109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1021/acs.chemrev.5b00109</a></cite> [<a href="https://doi.org/10.1021/acs.chemrev.5b00109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4688911/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26154342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Rev.&amp;title=Synthetic%20Nanoparticles%20for%20Vaccines%20and%20Immunotherapy&amp;author=D.%20J.%20Irvine&amp;author=M.%20C.%20Hanson&amp;author=K.%20Rakhra&amp;author=T.%20Tokatlian&amp;volume=115&amp;issue=19&amp;publication_year=2015&amp;pages=11109-11146&amp;pmid=26154342&amp;doi=10.1021/acs.chemrev.5b00109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit40">
<cite>Wei Z. Zhang Z. Yong T. Bie N. Zhan G. Li X. Liang Q. Li J. Yu J. Huang G. Yan Y. Zhang Z. Zhang B. Lu G. Huang B. Yang X. Boosting Anti-PD-1 Therapy with Metformin-Loaded Macrophage-Derived Microparticles. Nat. Commun. 2021;12:440–460. doi: 10.1038/s41467-020-20723-x. <a href="https://doi.org/10.1038/s41467-020-20723-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/s41467-020-20723-x</a></cite> [<a href="https://doi.org/10.1038/s41467-020-20723-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7815730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33469052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Boosting%20Anti-PD-1%20Therapy%20with%20Metformin-Loaded%20Macrophage-Derived%20Microparticles&amp;author=Z.%20Wei&amp;author=Z.%20Zhang&amp;author=T.%20Yong&amp;author=N.%20Bie&amp;author=G.%20Zhan&amp;volume=12&amp;publication_year=2021&amp;pages=440-460&amp;pmid=33469052&amp;doi=10.1038/s41467-020-20723-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit41">
<cite>Daughton C. G. Ruhoy I. S. Lower-Dose Prescribing: Minimizing “Side Effects” of Pharmaceuticals on Society and the Environment. Sci. Total Environ. 2013;443:324–337. doi: 10.1016/j.scitotenv.2012.10.092. <a href="https://doi.org/10.1016/j.scitotenv.2012.10.092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.scitotenv.2012.10.092</a></cite> [<a href="https://doi.org/10.1016/j.scitotenv.2012.10.092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23201698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Total%20Environ.&amp;title=Lower-Dose%20Prescribing:%20Minimizing%20%E2%80%9CSide%20Effects%E2%80%9D%20of%20Pharmaceuticals%20on%20Society%20and%20the%20Environment&amp;author=C.%20G.%20Daughton&amp;author=I.%20S.%20Ruhoy&amp;volume=443&amp;publication_year=2013&amp;pages=324-337&amp;pmid=23201698&amp;doi=10.1016/j.scitotenv.2012.10.092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit42">
<cite>Hansel T. T. Kropshofer H. Singer T. Mitchell J. A. George A. J. T. The Safety and Side Effects of Monoclonal Antibodies. Nat. Rev. Drug Discovery. 2010;9(4):325–338. doi: 10.1038/nrd3003. <a href="https://doi.org/10.1038/nrd3003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1038/nrd3003</a></cite> [<a href="https://doi.org/10.1038/nrd3003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20305665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discovery&amp;title=The%20Safety%20and%20Side%20Effects%20of%20Monoclonal%20Antibodies&amp;author=T.%20T.%20Hansel&amp;author=H.%20Kropshofer&amp;author=T.%20Singer&amp;author=J.%20A.%20Mitchell&amp;author=A.%20J.%20T.%20George&amp;volume=9&amp;issue=4&amp;publication_year=2010&amp;pages=325-338&amp;pmid=20305665&amp;doi=10.1038/nrd3003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit43">
<cite>Viola M. Sequeira J. Seiça R. Veiga F. Serra J. Santos A. C. Ribeiro A. J. Subcutaneous Delivery of Monoclonal Antibodies: How Do We Get There? J. Controlled Release. 2018;286:301–314. doi: 10.1016/j.jconrel.2018.08.001. <a href="https://doi.org/10.1016/j.jconrel.2018.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.jconrel.2018.08.001</a></cite> [<a href="https://doi.org/10.1016/j.jconrel.2018.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30077735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Subcutaneous%20Delivery%20of%20Monoclonal%20Antibodies:%20How%20Do%20We%20Get%20There?&amp;author=M.%20Viola&amp;author=J.%20Sequeira&amp;author=R.%20Sei%C3%A7a&amp;author=F.%20Veiga&amp;author=J.%20Serra&amp;volume=286&amp;publication_year=2018&amp;pages=301-314&amp;pmid=30077735&amp;doi=10.1016/j.jconrel.2018.08.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit44">
<cite>Lewis S. M. Williams A. Eisenbarth S. C. Structure and Function of the Immune System in the Spleen. Sci. Immunol. 2019;4(33):eaau6085. doi: 10.1126/sciimmunol.aau6085. <a href="https://doi.org/10.1126/sciimmunol.aau6085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1126/sciimmunol.aau6085</a></cite> [<a href="https://doi.org/10.1126/sciimmunol.aau6085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6495537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30824527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Immunol.&amp;title=Structure%20and%20Function%20of%20the%20Immune%20System%20in%20the%20Spleen&amp;author=S.%20M.%20Lewis&amp;author=A.%20Williams&amp;author=S.%20C.%20Eisenbarth&amp;volume=4&amp;issue=33&amp;publication_year=2019&amp;pages=eaau6085&amp;pmid=30824527&amp;doi=10.1126/sciimmunol.aau6085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit45">
<cite>Sayed K. A. E. Khanfar M. A. Shallal H. M. Muralidharan A. Awate B. Youssef D. T. A. Liu Y. Zhou Y.-D. Nagle D. G. Shah G. Latrunculin A and Its C-17-O-Carbamates Inhibit Prostate Tumor Cell Invasion and HIF-1 Activation in Breast Tumor Cells. J. Nat. Prod. 2008;71(3):396–402. doi: 10.1021/np070587w. <a href="https://doi.org/10.1021/np070587w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1021/np070587w</a></cite> [<a href="https://doi.org/10.1021/np070587w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2930178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18298079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nat.%20Prod.&amp;title=Latrunculin%20A%20and%20Its%20C-17-O-Carbamates%20Inhibit%20Prostate%20Tumor%20Cell%20Invasion%20and%20HIF-1%20Activation%20in%20Breast%20Tumor%20Cells&amp;author=K.%20A.%20E.%20Sayed&amp;author=M.%20A.%20Khanfar&amp;author=H.%20M.%20Shallal&amp;author=A.%20Muralidharan&amp;author=B.%20Awate&amp;volume=71&amp;issue=3&amp;publication_year=2008&amp;pages=396-402&amp;pmid=18298079&amp;doi=10.1021/np070587w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit46">
<cite>Shojaie L. Iorga A. Dara L. Cell Death in Liver Diseases: A Review. Int. J. Mol. Sci. 2020;21(24):9682. doi: 10.3390/ijms21249682. <a href="https://doi.org/10.3390/ijms21249682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.3390/ijms21249682</a></cite> [<a href="https://doi.org/10.3390/ijms21249682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7766597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33353156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Cell%20Death%20in%20Liver%20Diseases:%20A%20Review&amp;author=L.%20Shojaie&amp;author=A.%20Iorga&amp;author=L.%20Dara&amp;volume=21&amp;issue=24&amp;publication_year=2020&amp;pages=9682&amp;pmid=33353156&amp;doi=10.3390/ijms21249682&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit47">
<cite>Vincent M. P. Stack T. Vahabikashi A. Li G. Perkumas K. M. Ren R. Gong H. Stamer W. D. Johnson M. Scott E. A. Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy. ACS Appl. Mater. Interfaces. 2021;13(28):32823–32836. doi: 10.1021/acsami.1c09294. <a href="https://doi.org/10.1021/acsami.1c09294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1021/acsami.1c09294</a></cite> [<a href="https://doi.org/10.1021/acsami.1c09294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9131393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34232612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Surface%20Engineering%20of%20FLT4-Targeted%20Nanocarriers%20Enhances%20Cell-Softening%20Glaucoma%20Therapy&amp;author=M.%20P.%20Vincent&amp;author=T.%20Stack&amp;author=A.%20Vahabikashi&amp;author=G.%20Li&amp;author=K.%20M.%20Perkumas&amp;volume=13&amp;issue=28&amp;publication_year=2021&amp;pages=32823-32836&amp;pmid=34232612&amp;doi=10.1021/acsami.1c09294&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit48">
<cite>Yuk S. A. Kim H. Abutaleb N. S. Dieterly A. M. Taha M. S. Tsifansky M. D. Lyle L. T. Seleem M. N. Yeo Y. Nanocapsules Modify Membrane Interaction of Polymyxin B to Enable Safe Systemic Therapy of Gram-negative Sepsis. Sci. Adv. 2021;7(32):eabj1577. doi: 10.1126/sciadv.abj1577. <a href="https://doi.org/10.1126/sciadv.abj1577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1126/sciadv.abj1577</a></cite> [<a href="https://doi.org/10.1126/sciadv.abj1577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8346222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34362742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Adv.&amp;title=Nanocapsules%20Modify%20Membrane%20Interaction%20of%20Polymyxin%20B%20to%20Enable%20Safe%20Systemic%20Therapy%20of%20Gram-negative%20Sepsis&amp;author=S.%20A.%20Yuk&amp;author=H.%20Kim&amp;author=N.%20S.%20Abutaleb&amp;author=A.%20M.%20Dieterly&amp;author=M.%20S.%20Taha&amp;volume=7&amp;issue=32&amp;publication_year=2021&amp;pages=eabj1577&amp;pmid=34362742&amp;doi=10.1126/sciadv.abj1577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit49">
<cite>Siwicki M. Gort-Freitas N. A. Messemaker M. Bill R. Gungabeesoon J. Engblom C. Zilionis R. Garris C. Gerhard G. M. Kohl A. Lin Y. Zou A. E. Cianciaruso C. Bolli E. Pfirschke C. Lin Y.-J. Piot C. Mindur J. E. Talele N. Kohler R. H. Iwamoto Y. Mino-Kenudson M. Pai S. I. deVito C. Koessler T. Merkler D. Coukos A. Wicky A. Fraga M. Sempoux C. Jain R. K. Dietrich P.-Y. Michielin O. Weissleder R. Klein A. M. Pittet M. J. Resident Kupffer Cells and Neutrophils Drive Liver Toxicity in Cancer Immunotherapy. Sci. Immunol. 2021;6(61):eabi7083. doi: 10.1126/sciimmunol.abi7083. <a href="https://doi.org/10.1126/sciimmunol.abi7083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1126/sciimmunol.abi7083</a></cite> [<a href="https://doi.org/10.1126/sciimmunol.abi7083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8845079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34215680/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Immunol.&amp;title=Resident%20Kupffer%20Cells%20and%20Neutrophils%20Drive%20Liver%20Toxicity%20in%20Cancer%20Immunotherapy&amp;author=M.%20Siwicki&amp;author=N.%20A.%20Gort-Freitas&amp;author=M.%20Messemaker&amp;author=R.%20Bill&amp;author=J.%20Gungabeesoon&amp;volume=6&amp;issue=61&amp;publication_year=2021&amp;pages=eabi7083&amp;pmid=34215680&amp;doi=10.1126/sciimmunol.abi7083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit50">
<cite>Van Rooijen N. Van Kesteren-Hendrikx E. Clodronate Liposomes: Perspectives In Research And Therapeutics. J. Liposome Res. 2002;12(1–2):81–94. doi: 10.1081/LPR-120004780. <a href="https://doi.org/10.1081/LPR-120004780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1081/LPR-120004780</a></cite> [<a href="https://doi.org/10.1081/LPR-120004780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12604042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Liposome%20Res.&amp;title=Clodronate%20Liposomes:%20Perspectives%20In%20Research%20And%20Therapeutics&amp;author=N.%20Van%20Rooijen&amp;author=E.%20Van%20Kesteren-Hendrikx&amp;volume=12&amp;issue=1%E2%80%932&amp;publication_year=2002&amp;pages=81-94&amp;pmid=12604042&amp;doi=10.1081/LPR-120004780&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit51">
<cite>Jönsson F. Gurniak C. B. Fleischer B. Kirfel G. Witke W. Immunological Responses and Actin Dynamics in Macrophages Are Controlled by N-Cofilin but Are Independent from ADF. PLoS One. 2012;7(4):e36034. doi: 10.1371/journal.pone.0036034. <a href="https://doi.org/10.1371/journal.pone.0036034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1371/journal.pone.0036034</a></cite> [<a href="https://doi.org/10.1371/journal.pone.0036034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3338623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22558315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Immunological%20Responses%20and%20Actin%20Dynamics%20in%20Macrophages%20Are%20Controlled%20by%20N-Cofilin%20but%20Are%20Independent%20from%20ADF&amp;author=F.%20J%C3%B6nsson&amp;author=C.%20B.%20Gurniak&amp;author=B.%20Fleischer&amp;author=G.%20Kirfel&amp;author=W.%20Witke&amp;volume=7&amp;issue=4&amp;publication_year=2012&amp;pages=e36034&amp;pmid=22558315&amp;doi=10.1371/journal.pone.0036034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit52">
<cite>Simonetti B. Cullen P. J. Actin-Dependent Endosomal Receptor Recycling. Curr. Opin. Cell Biol. 2019;56:22–33. doi: 10.1016/j.ceb.2018.08.006. <a href="https://doi.org/10.1016/j.ceb.2018.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.ceb.2018.08.006</a></cite> [<a href="https://doi.org/10.1016/j.ceb.2018.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30227382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Opin.%20Cell%20Biol.&amp;title=Actin-Dependent%20Endosomal%20Receptor%20Recycling&amp;author=B.%20Simonetti&amp;author=P.%20J.%20Cullen&amp;volume=56&amp;publication_year=2019&amp;pages=22-33&amp;pmid=30227382&amp;doi=10.1016/j.ceb.2018.08.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit53">
<cite>Cendrowski J. Mamińska A. Miaczynska M. Endocytic Regulation of Cytokine Receptor Signaling. Cytokine Growth Factor Rev. 2016;32:63–73. doi: 10.1016/j.cytogfr.2016.07.002.</cite> [<a href="https://doi.org/10.1016/j.cytogfr.2016.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27461871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine%20Growth%20Factor%20Rev.&amp;title=Endocytic%20Regulation%20of%20Cytokine%20Receptor%20Signaling&amp;author=J.%20Cendrowski&amp;author=A.%20Mami%C5%84ska&amp;author=M.%20Miaczynska&amp;volume=32&amp;publication_year=2016&amp;pages=63-73&amp;pmid=27461871&amp;doi=10.1016/j.cytogfr.2016.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit54">
<cite>Lin W.-W. Lu Y.-C. Chuang C.-H. Cheng T.-L. Ab Locks for Improving the Selectivity and Safety of Antibody Drugs. J. Biomed. Sci. 2020;27(1):76. doi: 10.1186/s12929-020-00652-z. <a href="https://doi.org/10.1186/s12929-020-00652-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1186/s12929-020-00652-z</a></cite> [<a href="https://doi.org/10.1186/s12929-020-00652-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7318374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32586313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomed.%20Sci.&amp;title=Ab%20Locks%20for%20Improving%20the%20Selectivity%20and%20Safety%20of%20Antibody%20Drugs&amp;author=W.-W.%20Lin&amp;author=Y.-C.%20Lu&amp;author=C.-H.%20Chuang&amp;author=T.-L.%20Cheng&amp;volume=27&amp;issue=1&amp;publication_year=2020&amp;pages=76&amp;pmid=32586313&amp;doi=10.1186/s12929-020-00652-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit55">
<cite>Wang L.-X. Tong X. Li C. Giddens J. P. Li T. Glycoengineering of Antibodies for Modulating Functions. Annu. Rev. Biochem. 2019;88:433–459. doi: 10.1146/annurev-biochem-062917-012911. <a href="https://doi.org/10.1146/annurev-biochem-062917-012911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1146/annurev-biochem-062917-012911</a></cite> [<a href="https://doi.org/10.1146/annurev-biochem-062917-012911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6923169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30917003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Biochem.&amp;title=Glycoengineering%20of%20Antibodies%20for%20Modulating%20Functions&amp;author=L.-X.%20Wang&amp;author=X.%20Tong&amp;author=C.%20Li&amp;author=J.%20P.%20Giddens&amp;author=T.%20Li&amp;volume=88&amp;publication_year=2019&amp;pages=433-459&amp;pmid=30917003&amp;doi=10.1146/annurev-biochem-062917-012911&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit56">
<cite>Korn E. L. Moscow J. A. Freidlin B. Dose Optimization during Drug Development: Whether and When to Optimize. J. Natl. Cancer Inst. 2023;115(5):492–497. doi: 10.1093/jnci/djac232. <a href="https://doi.org/10.1093/jnci/djac232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1093/jnci/djac232</a></cite> [<a href="https://doi.org/10.1093/jnci/djac232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10165487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36534891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Dose%20Optimization%20during%20Drug%20Development:%20Whether%20and%20When%20to%20Optimize&amp;author=E.%20L.%20Korn&amp;author=J.%20A.%20Moscow&amp;author=B.%20Freidlin&amp;volume=115&amp;issue=5&amp;publication_year=2023&amp;pages=492-497&amp;pmid=36534891&amp;doi=10.1093/jnci/djac232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cit57">
<cite>Yi S. Kim S.-Y. Vincent M. P. Yuk S. A. Bobbala S. Du F. Scott E. A. Dendritic Peptide-Conjugated Polymeric Nanovectors for Non-Toxic Delivery of Plasmid DNA and Enhanced Non-Viral Transfection of Immune Cells. iScience. 2022;25(7):104555. doi: 10.1016/j.isci.2022.104555. <a href="https://doi.org/10.1016/j.isci.2022.104555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://dx.doi.org/10.1016/j.isci.2022.104555</a></cite> [<a href="https://doi.org/10.1016/j.isci.2022.104555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9234717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35769884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=iScience&amp;title=Dendritic%20Peptide-Conjugated%20Polymeric%20Nanovectors%20for%20Non-Toxic%20Delivery%20of%20Plasmid%20DNA%20and%20Enhanced%20Non-Viral%20Transfection%20of%20Immune%20Cells&amp;author=S.%20Yi&amp;author=S.-Y.%20Kim&amp;author=M.%20P.%20Vincent&amp;author=S.%20A.%20Yuk&amp;author=S.%20Bobbala&amp;volume=25&amp;issue=7&amp;publication_year=2022&amp;pages=104555&amp;pmid=35769884&amp;doi=10.1016/j.isci.2022.104555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>NH-010-D5NH00206K-s001</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12186146/bin/NH-010-D5NH00206K-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">NH-010-D5NH00206K-s001.pdf</a><sup> (6.5MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The authors confirm that the data supporting the findings of this work is available within the article. The raw data is also accessible from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nanoscale Horizons are provided here courtesy of <strong>Royal Society of Chemistry</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1039/d5nh00206k"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12186146/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12186146/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12186146%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12186146/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12186146/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40552380/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12186146/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40552380/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12186146/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12186146/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="28vVUkr5rTEIpVm2Jxjl97HdKuwkytaJp45HRqYUsJWa2dSI1njfm08QjbfbTd1s">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
